EP2178922B1 - Polymer hydrogels and methods of preparation thereof - Google Patents
Polymer hydrogels and methods of preparation thereof Download PDFInfo
- Publication number
- EP2178922B1 EP2178922B1 EP08785471.7A EP08785471A EP2178922B1 EP 2178922 B1 EP2178922 B1 EP 2178922B1 EP 08785471 A EP08785471 A EP 08785471A EP 2178922 B1 EP2178922 B1 EP 2178922B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- acid
- polymer
- polymer hydrogel
- water
- hydrogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920000642 polymer Polymers 0.000 title claims description 249
- 239000000017 hydrogel Substances 0.000 title claims description 200
- 238000000034 method Methods 0.000 title claims description 68
- 238000002360 preparation method Methods 0.000 title description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 216
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 102
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 63
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 63
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 63
- 230000008961 swelling Effects 0.000 claims description 59
- 235000015165 citric acid Nutrition 0.000 claims description 41
- 239000002253 acid Substances 0.000 claims description 31
- 239000007864 aqueous solution Substances 0.000 claims description 30
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 30
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 28
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 28
- 229920000831 ionic polymer Polymers 0.000 claims description 28
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 27
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 27
- 229940105329 carboxymethylcellulose Drugs 0.000 claims description 27
- 229920002678 cellulose Polymers 0.000 claims description 23
- 235000010980 cellulose Nutrition 0.000 claims description 23
- 238000010438 heat treatment Methods 0.000 claims description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 21
- 239000001913 cellulose Substances 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 20
- 238000001035 drying Methods 0.000 claims description 16
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 14
- 229920013820 alkyl cellulose Polymers 0.000 claims description 14
- 239000000600 sorbitol Substances 0.000 claims description 14
- -1 n-propylcellulose Polymers 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 239000002250 absorbent Substances 0.000 claims description 11
- 230000002745 absorbent Effects 0.000 claims description 11
- 229920002472 Starch Polymers 0.000 claims description 9
- 235000019698 starch Nutrition 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 claims description 8
- 150000000000 tetracarboxylic acids Chemical class 0.000 claims description 7
- 150000003628 tricarboxylic acids Chemical class 0.000 claims description 7
- 229920002307 Dextran Polymers 0.000 claims description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 6
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 claims description 6
- 238000013270 controlled release Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 235000015097 nutrients Nutrition 0.000 claims description 5
- 239000003495 polar organic solvent Substances 0.000 claims description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 claims description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- CYIDZMCFTVVTJO-UHFFFAOYSA-N pyromellitic acid Chemical compound OC(=O)C1=CC(C(O)=O)=C(C(O)=O)C=C1C(O)=O CYIDZMCFTVVTJO-UHFFFAOYSA-N 0.000 claims description 4
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 claims description 4
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 claims description 4
- KQTIIICEAUMSDG-UHFFFAOYSA-N tricarballylic acid Chemical compound OC(=O)CC(C(O)=O)CC(O)=O KQTIIICEAUMSDG-UHFFFAOYSA-N 0.000 claims description 4
- 229920000896 Ethulose Polymers 0.000 claims description 3
- 239000001856 Ethyl cellulose Substances 0.000 claims description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 3
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 3
- 229920002230 Pectic acid Polymers 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229960002086 dextran Drugs 0.000 claims description 3
- 229960000633 dextran sulfate Drugs 0.000 claims description 3
- 150000002016 disaccharides Chemical class 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 229920001249 ethyl cellulose Polymers 0.000 claims description 3
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 3
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229920000609 methyl cellulose Polymers 0.000 claims description 3
- 239000001923 methylcellulose Substances 0.000 claims description 3
- 150000002772 monosaccharides Chemical class 0.000 claims description 3
- 239000010318 polygalacturonic acid Substances 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 150000005846 sugar alcohols Chemical class 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- GGAUUQHSCNMCAU-ZXZARUISSA-N (2s,3r)-butane-1,2,3,4-tetracarboxylic acid Chemical compound OC(=O)C[C@H](C(O)=O)[C@H](C(O)=O)CC(O)=O GGAUUQHSCNMCAU-ZXZARUISSA-N 0.000 claims description 2
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 claims description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 claims description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 2
- NBAUUNCGSMAPFM-UHFFFAOYSA-N 3-(3,4-dicarboxyphenyl)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C1=CC=CC(C(O)=O)=C1C(O)=O NBAUUNCGSMAPFM-UHFFFAOYSA-N 0.000 claims description 2
- UITKHKNFVCYWNG-UHFFFAOYSA-N 4-(3,4-dicarboxybenzoyl)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 UITKHKNFVCYWNG-UHFFFAOYSA-N 0.000 claims description 2
- GEYAGBVEAJGCFB-UHFFFAOYSA-N 4-[2-(3,4-dicarboxyphenyl)propan-2-yl]phthalic acid Chemical compound C=1C=C(C(O)=O)C(C(O)=O)=CC=1C(C)(C)C1=CC=C(C(O)=O)C(C(O)=O)=C1 GEYAGBVEAJGCFB-UHFFFAOYSA-N 0.000 claims description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- 229920002567 Chondroitin Polymers 0.000 claims description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 2
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 claims description 2
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 claims description 2
- 239000004386 Erythritol Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- 229920002971 Heparan sulfate Polymers 0.000 claims description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 2
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 229940091181 aconitic acid Drugs 0.000 claims description 2
- 239000001361 adipic acid Substances 0.000 claims description 2
- 235000011037 adipic acid Nutrition 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims description 2
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 2
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 claims description 2
- STZIXLPVKZUAMV-UHFFFAOYSA-N cyclopentane-1,1,2,2-tetracarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCCC1(C(O)=O)C(O)=O STZIXLPVKZUAMV-UHFFFAOYSA-N 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- 229960002897 heparin Drugs 0.000 claims description 2
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims description 2
- 229940099552 hyaluronan Drugs 0.000 claims description 2
- 239000000905 isomalt Substances 0.000 claims description 2
- 235000010439 isomalt Nutrition 0.000 claims description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 2
- 239000000832 lactitol Substances 0.000 claims description 2
- 235000010448 lactitol Nutrition 0.000 claims description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 2
- 229960003451 lactitol Drugs 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 229960001375 lactose Drugs 0.000 claims description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 2
- 239000011976 maleic acid Substances 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- 239000000845 maltitol Substances 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 235000010449 maltitol Nutrition 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- 229960002160 maltose Drugs 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 229960001855 mannitol Drugs 0.000 claims description 2
- HDLRSIQOZFLEPK-UHFFFAOYSA-N naphthalene-1,2,5,8-tetracarboxylic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C2=C(C(O)=O)C(C(=O)O)=CC=C21 HDLRSIQOZFLEPK-UHFFFAOYSA-N 0.000 claims description 2
- DSCIZKMHZPGBNI-UHFFFAOYSA-N naphthalene-1,3,5,8-tetracarboxylic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C2=CC(C(=O)O)=CC(C(O)=O)=C21 DSCIZKMHZPGBNI-UHFFFAOYSA-N 0.000 claims description 2
- DOBFTMLCEYUAQC-UHFFFAOYSA-N naphthalene-2,3,6,7-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=C2C=C(C(O)=O)C(C(=O)O)=CC2=C1 DOBFTMLCEYUAQC-UHFFFAOYSA-N 0.000 claims description 2
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 claims description 2
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 claims description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
- 229940074410 trehalose Drugs 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 239000000590 phytopharmaceutical Substances 0.000 claims 1
- 238000004132 cross linking Methods 0.000 description 50
- 238000006243 chemical reaction Methods 0.000 description 47
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 46
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 33
- 239000012530 fluid Substances 0.000 description 23
- 239000000203 mixture Substances 0.000 description 21
- 239000000499 gel Substances 0.000 description 20
- 238000010521 absorption reaction Methods 0.000 description 19
- 230000008569 process Effects 0.000 description 19
- 230000015572 biosynthetic process Effects 0.000 description 18
- 239000000463 material Substances 0.000 description 18
- 239000012153 distilled water Substances 0.000 description 16
- 235000013305 food Nutrition 0.000 description 16
- 150000008064 anhydrides Chemical group 0.000 description 14
- 239000003431 cross linking reagent Substances 0.000 description 14
- 125000006850 spacer group Chemical group 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 12
- 229920000247 superabsorbent polymer Polymers 0.000 description 11
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 10
- 230000002496 gastric effect Effects 0.000 description 9
- 230000035484 reaction time Effects 0.000 description 9
- 210000000813 small intestine Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 229920006318 anionic polymer Polymers 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000037406 food intake Effects 0.000 description 8
- 235000012631 food intake Nutrition 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000002243 precursor Substances 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 230000015556 catabolic process Effects 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 125000000524 functional group Chemical group 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 238000001228 spectrum Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 150000001718 carbodiimides Chemical class 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 238000005886 esterification reaction Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 4
- 229920006317 cationic polymer Polymers 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 125000002887 hydroxy group Chemical class [H]O* 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 239000002798 polar solvent Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000036186 satiety Effects 0.000 description 4
- 235000019627 satiety Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000005102 attenuated total reflection Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 150000001991 dicarboxylic acids Chemical class 0.000 description 3
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000000643 oven drying Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- WQNHWIYLCRZRLR-UHFFFAOYSA-N 2-(3-hydroxy-2,5-dioxooxolan-3-yl)acetic acid Chemical compound OC(=O)CC1(O)CC(=O)OC1=O WQNHWIYLCRZRLR-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010007558 Cardiac failure chronic Diseases 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- PPQREHKVAOVYBT-UHFFFAOYSA-H dialuminum;tricarbonate Chemical compound [Al+3].[Al+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O PPQREHKVAOVYBT-UHFFFAOYSA-H 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000000113 differential scanning calorimetry Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 239000001341 hydroxy propyl starch Substances 0.000 description 2
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000017807 phytochemicals Nutrition 0.000 description 2
- 229930000223 plant secondary metabolite Natural products 0.000 description 2
- 229920000867 polyelectrolyte Polymers 0.000 description 2
- 229920002959 polymer blend Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000013222 sprague-dawley male rat Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102100026933 Myelin-associated neurite-outgrowth inhibitor Human genes 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 235000020827 calorie restriction Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000010889 donnan-equilibrium Methods 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000007863 gel particle Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 235000006796 hypocaloric diet Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 229960003174 lansoprazole Drugs 0.000 description 1
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000006742 locomotor activity Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002106 nanomesh Substances 0.000 description 1
- 229960004872 nizatidine Drugs 0.000 description 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229960005019 pantoprazole Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 239000012704 polymeric precursor Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940126409 proton pump inhibitor Drugs 0.000 description 1
- 239000000612 proton pump inhibitor Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000007492 two-way ANOVA Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/246—Intercrosslinking of at least two polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/738—Cross-linked polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
- C08B15/005—Crosslinking of cellulose derivatives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
- C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
- C08B15/04—Carboxycellulose, e.g. prepared by oxidation with nitrogen dioxide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2301/08—Cellulose derivatives
- C08J2301/26—Cellulose ethers
- C08J2301/28—Alkyl ethers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/30—Fuel from waste, e.g. synthetic alcohol or diesel
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W30/00—Technologies for solid waste management
- Y02W30/40—Bio-organic fraction processing; Production of fertilisers from the organic fraction of waste or refuse
Definitions
- the present invention relates to polymer hydrogels and methods of preparation thereof.
- Polymer hydrogels are cross-linked hydrophilic polymers which are capable of absorbing high amounts of water.
- cross-linked polymer hydrogels capable of absorbing an amount of water in excess of 10 times their dry weight are defined as "superabsorbent". Some of these materials are even capable of absorbing over 1 litre of water per gram of dry polymer.
- cross-links or cross-linking knots i.e. the physical or chemical bonds between the macromolecular chains forming the polymer hydrogel network, guarantee the structural integrity of the polymer-liquid system, on the one hand preventing the complete solubilisation of the polymer, and on the other hand allowing the retention of the aqueous phase within the molecular mesh.
- the superabsorbent polymer hydrogels which are currently available on the market are characterised not only by their marked absorbent properties, but also by their biocompatibility, which is probably due to the high water content, and, above all, by the possibility of adjusting their absorption properties according to the external stimuli. Consequently, such polymer hydrogels may be used as intelligent materials, for example for the manufacture of sensors or actuators for a number of industrial applications.
- absorbent cores in the field of personal hygiene absorbent products there are more recent and innovative applications such as for example in the biomedical field, for the development of controlled release drug formulations, artificial muscles, sensors, etc., and in agriculture and horticulture, for example in devices for the controlled release of water and nutrients in arid soils.
- biodegradable polymers used to obtain superabsorbent polymer hydrogels are starch and cellulose derivatives.
- Anbergen and Oppermann proposed a method for the synthesis of a superabsorbent material made entirely from cellulose derivatives.
- HEC hydroxyethylcellulose
- CMCNa carboxymethylcellulose sodium salt
- the absorption properties of such materials are not high compared to those of the acrylic-based superabsorbent materials.
- CMCNa may be chemically cross-linked with any reagent which is bifunctional with respect to cellulose.
- any reagent which is bifunctional with respect to cellulose.
- divinylsulphone used in the synthetic process according to Anbergen and Opperman
- epichlorhydrin, formaldehyde and various diepoxides have also been used as cross-linking agents.
- such compounds are highly toxic in their unreacted states [3].
- Some carbodiimides are known amongst the unconventional cross-linking agents. Particularly, the use of carbodiimides in order to cross-link salified or non-salified carboxymethylcellulose (CMC) was described in [4].
- Carbodiimides induce the formation of ester bonds between cellulose macromolecules without participating in the bonds themselves, instead giving rise to a urea derivative having very low toxicity [5].
- a superabsorbent polymer hydrogel obtained by cross-linking carboxymethylcellulose sodium salt and hydroxyethylcellulose with carbodiimide as the cross-linking agent is disclosed in the international patent application WO 2006/070337 [6].
- WO 96/02276 describes a cross-linked, responsive polymer gel network comprising polymer chains interconnected by way of a multifunctional cross-linker and methods of preparing such polymer gels.
- the object of the present invention is to provide polymer hydrogels which overcome the above-mentioned disadvantages associated with the use of carbodiimide as a cross-linking agent.
- the polymer hydrogels of the invention are based on the use of a polycarboxylic acid, such as citric acid, as the cross-linking agent, and in preferred embodiments, also include the use of a molecular spacer.
- a polycarboxylic acid such as citric acid
- the invention relates, in part, to the discovery that the cross-linking of soluble cellulose derivatives with citric acid (3-carboxy-3-hydroxy-1,5-pentanedioic acid; hereinafter designated "CA") results in the formation of polymer hydrogels and superabsorbent polymer hydrogels.
- CA is naturally occurring, non-toxic and available on the market at low cost.
- CA has been reported as a cross-linking agent for polymers such as cellulose, hydroxypropylmethylcellulose and starch, in textile and food applications [7-11], in these applications CA is used to cross-link and further stabilize insoluble fibers, to provide a fabric with enhanced resiliency and mechanical properties.
- CA to cross-link carboxymethylcellulose or other soluble hydrophilic polymers for preparing polymer hydrogels and superabsorbent polymer hydrogels has not been previously disclosed.
- One aspect of the present invention provides a method of preparing a polymer hydrogel comprising the steps of (a) preparing an aqueous solution comprising one or more hydrophilic polymers, a polycarboxylic acid selected from C 4 -C 12 -dicarboxylic acids, tricarboxylic acids and tetracarboxylic acids and a polyhydroxylated compound selected from plant glycerol, monosaccharides, disaccharides and sugar alcohols; and (b) heating the aqueous solution to remove water and cross-link the one or more hydrophilic polymers, thereby forming a polymer hydrogel.
- the aqueous solution comprises two or more hydrophilic polymers, such as, for example, hydroxylated polymers.
- the aqueous solution can comprise a first hydrophilic polymer and a second hydrophilic polymer, which can be present in the same or different amounts on a weight basis.
- the first hydrophilic polymer is an ionic polymer and the second polymer is a nonionic polymer.
- Also described is a method for preparing a polymer hydrogel comprising the steps of (a) providing an aqueous solution of carboxymethylcellulose, hydroxyethylcellulose, citric acid and a molecular spacer; (b) heating the aqueous solution, thereby evaporating the water and cross-linking the carboxymethylcellulose and hydroxyethylcellulose to form a polymer hydrogel material; (c) washing the polymer hydrogel material with water or a polar organic solvent to form a washed polymer hydrogel; (d) immersing the washed polymer hydrogel in a cellulose nonsolvent, thereby producing a dried polymer hydrogel;
- a second aspect of the present invention provides a method of producing a polymer hydrogel comprising the steps of (a) preparing an aqueous solution of carboxymethylcellulose, preferably carboxymethylcellulose sodium salt, and citric acid: (b) heating the aqueous solution to remove water and cross-link the carboxymethylcellulose, thereby forming a polymer hydrogel; (c) washing the polymer hydrogel with water, a polar organic solvent or a combination thereof, thereby producing a washed polymer hydrogel; and (d) drying the washed polymer hydrogel by immersing the washed polymer hydrogel in a cellulose nonsolvent, thereby producing the polymer hydrogel.
- a third aspect of the present invention provides polymer hydrogels, such as superabsorbent polymer hydrogels, which can be prepared using the methods of the invention.
- Such polymer hydrogels comprise at least one hydrophilic polymer cross-linked with a polycarboxylic acid.
- a fourth aspect of the present invention provides articles of manufacture which comprise such polymer hydrogels.
- the present invention provides polymer hydrogels, methods of preparing the polymer hydrogels, and articles of manufacture comprising the polymer hydrogels.
- the methods of preparing a polymer hydrogel of the present invention comprise the step of cross-linking an aqueous solution comprising a hydrophilic polymer with a polycarboxylic acid, thereby producing the polymer hydrogel.
- the aqueous solution comprises two or more hydrophilic polymers.
- the aqueous solution can comprise a first hydrophilic polymer and a second hydrophilic polymer, which can be present in the same or different amounts on a weight basis.
- the first hydrophilic polymer is an ionic polymer and the second polymer is a nonionic polymer.
- the cross-linking reaction is preferably conducted at elevated temperature, for example, at a temperature greater than room temperature (25°C).
- the reaction can be conducted at a temperature from about 30°C to about 150°C, preferably from about 50°C to about 120°C.
- the reaction solution is concentrated by removal of water. The removal of water can be accomplished, for example, by evaporation. In one embodiment, a fraction of the water is removed. In another embodiment, substantially all of the water is removed, thereby producing a dry residue.
- the reaction mixture is maintained at elevated temperature for a period of time following removal of water to dryness.
- hydrophilic polymer refers to a polymer which is substantially water-soluble and, preferably, includes monomeric units which are hydroxylated.
- a hydrophilic polymer can be a homopolymer, which includes only one repeating monomeric unit, or a copolymer, comprising two or more different repeating monomeric units.
- the hydrophilic polymer is hydroxylated, such as polyallyl alcohol, polyvinyl alcohol or a polysaccharide. Examples of suitable polysaccharides include substituted celluloses, substituted dextrans, starches and substituted starches, glycosaminoglycans, chitosan and alginates.
- Polysaccharides which can be used include alkylcelluloses, such as C 1 -C 6 -alkylcelluloses, including methylcellulose, ethylcellulose and n-propylcellulose; substituted alkylcelluloses, including hydroxy-C 1 -C 6 -alkylcelluloses and hydroxy-C 1 -C 6 -alkyl-C 1 -C 6 -alkylcelluloses, such as hydroxyethylcellulose, hydroxy-n-propylcellulose, hydroxy-n-butylcellulose, hydroxypropylmethylcellulose, ethylhydroxyethylcellulose and carboxymethylcellulose; starches, such as corn starch, hydroxypropylstarch and carboxymethylstarch; substituted dextrans, such as dextran sulfate, dextran phosphate and diethylaminodextran; glycosaminoglycans, including heparin, hyaluronan, chondroitin, chondroitin s
- ionic polymer refers to a polymer comprising monomeric units having an acidic functional group, such as a carboxyl, sulfate, sulfonate, phosphate or phosphonate group, or a basic functional group, such as an amino, substituted amino or guanidyl group.
- an ionic polymer comprising acidic functional groups will be a polyanion, and such a polymer is referred to herein as an "anionic polymer”.
- an ionic polymer comprising basic functional groups will be a polycation.
- ionic polymer such as an "cationic polymer".
- anionic polymer include alginate, dextran sulfate, carboxymethylcellulose, hyaluronic acid, polyglucuronic acid, polymanuronic acid, polygalacturonic acid, polyarabinic acid; chrondroitin sulfate and dextran phosphate.
- Suitable cationic polymers include chitosan and dimethylaminodextran.
- a preferred ionic polymer is carboxymethylcellulose, which can be used in the acid form, or as a salt with a suitable cation, such as sodium or potassium.
- nonionic polymer refers to a hydrophilic polymer which does not comprise monomeric units having ionizable functional groups, such as acidic or basic groups. Such a polymer will be uncharged in aqueous solution.
- suitable nonionic polymers for use in the present method are polyallylalcohol, polyvinylalcohol, starches, such as corn starch and hydroxypropylstarch, alkylcelluloses, such as C 1 -C 6 -alkylcelluloses, including methylcellulose, ethylcellulose and n-propylcellulose; substituted alkylcelluloses, including hydroxy-C 1 -C 6 -alkylcelluloses and hydroxy-C 1 -C 6 -alkyl-C 1 -C 6 -alkylcelluloses, such as hydroxyethylcellulose, hydroxy-n-propylcellulose, hydroxy-n-butylcellulose, hydroxypropylmethylcellulose, and ethylhydroxyethylcellulose.
- alkylcelluloses such as C 1 -C 6 -alkylcelluloses, including methylcellulose, ethylcellulose and n-propylcellulose
- substituted alkylcelluloses including hydroxy-C 1 -C 6
- polycarboxylic acid refers to an organic acid having two or more carboxylic acid functional groups, such as dicarboxylic acids, tricarboxylic acids and tetracarboxylic acids, aand also includes the anhydride forms of such organic acids.
- Dicarboxylic acids include oxalic acid, malonic acid, maleic acid, malic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, phthalic acid, o-phthalic acid, isophthalic acid, m -phthalic acid, and terephthalic acid.
- Preferred dicarboxylic acids include C 4 -C 12 - dicarboxylic acids.
- Suitable tricarboxylic acids include citric acid, isocitric acid, aconitic acid, and propane-1,2,3-tricarboxylic acid.
- Suitable tetracarboxylic acids include pyromellitic acid, 2,3,3',4'-biphenyltetracarboxylic acid, 3,3',4,4'-tetracarboxydiphenylether, 2,3',3,4'-tetracarboxydiphenylether, 3,3',4,4'-benzophenonetetracarboxylic acid, 2,3,6,7-tetracarboxynaphthalene, 1,4,5,7-tetracarboxynaphthalene, 1,4,5,6-tetracarboxynaphthalene, 3,3',4,4'-tetracarboxydiphenylmethane, 2,2-bis(3,4-dicarboxyphenyl)propane, butanetetracarboxylic acid, and cyclopentanetetracarboxylic acid.
- a particularly preferred polycarboxylic acid is citric acid.
- the method can further include the steps of purifying the polymer hydrogel, for example, by washing the polymer hydrogel in a polar solvent, such as water, a polar organic solvent, for example, an alcohol, such as methanol or ethanol, or a combination thereof.
- a polar solvent such as water
- a polar organic solvent for example, an alcohol, such as methanol or ethanol, or a combination thereof.
- the polymer hydrogel immersed in the polar solvent swells and releases any component, such as by-products or unreacted polycarboxylic acid, that was not incorporated into the polymer network.
- Water is preferred as the polar solvent, distilled water is still more preferred.
- the volume of water required during this step to reach the maximum swelling degree of the gel is approximately 10- to 20-fold greater than the initial volume of the gel itself.
- the polymer hydrogel washing step may be repeated more than once, optionally changing the polar solvent employed.
- the polymer hydrogel can be washed with methanol or ethanol followed by distilled water, with these two steps optionally repeated one or more times.
- the method can further include drying of the polymer hydrogel.
- the drying step is carried out by immersing the fully swollen polymer hydrogel in a cellulose nonsolvent, a process known as phase inversion.
- a cellulose nonsolvent include, for example, acetone and ethanol. Drying the polymer hydrogel by phase inversion results in a final microporous structure which improves the absorption properties of the polymer hydrogel by capillarity. Moreover, if the porosity is interconnected or open, i.e. the micropores communicate with one another, the absorption/desorption kinetics of the gel will be improved as well.
- acetone/water mixture is formed which increases in water content as the polymer hydrogel dries; at a certain acetone/water concentration, for example, about 55% in acetone, water is no longer able to exit from the polymer hydrogel, and thus fresh acetone has to be added to the polymer hydrogel to proceed with the drying process.
- acetone/water ratio the faster is the drying process.
- Pore dimensions are affected by the rate of the drying process and the initial dimensions of the polymer hydrogel particles: larger particles and a faster process tend to increase the pore dimensions; pore dimensions in the microscale range are preferred, as pores in this size range exhibit a strong capillary effect, resulting in the higher sorption and water retention capacity.
- the polymer hydrogels of the invention can also be dried by another process, such as air drying, freeze drying or oven drying. These drying methods can be used alone, in combination, or in combination with the non-solvent drying step described above.
- the polymer hydrogel can be dried in a non-solvent, followed by air drying, freeze drying, oven drying, o a combination thereof to eliminate any residual traces of nonsolvent.
- Oven drying can be carried out at a temperature of e.g. approximately 30-45°C until the residual nonsolvent is completely removed.
- the washed and dried polymer hydrogel can then be used as is, or can be milled to produce polymer hydrogel particles of a desired size.
- the cross-linking solution can optionally include a compound which serves as a molecular spacer.
- a "molecular spacer”, as this term is used herein, is a polyhydroxylated compound which, although not taking part in the reaction resulting in the formation of the cross-linked polymer hydrogel network to a significant extent, results in a polymer hydrogel with an increased absorption capacity. Although in certain cases the molecular spacer may participate in the cross-linking reaction to a small extent, it is believed that molecular spacers function by sterically blocking access to the polymer chains, thereby increasing the average distance between the polymer chains.
- Suitable compounds for use as molecular spacers in the methods of the present invention include monosaccharides, disaccharides and sugar alcohols, including sucrose, sorbitol, plant glycerol, mannitol, trehalose, lactose, maltose, erythritol, xylitol, lactitol, maltitol, arabitol, glycerol, isomalt and cellobiose.
- the molecular spacer is preferably included in the cross-linking solution in the amount of about 0.5% to about 10% by weight relative to the solvent, more preferably about 2% to about 8% and more preferably about 4%.
- the molecular spacer used to synthesise the polymer hydrogel is selected from the group consisting of sorbitol, sucrose and plant glycerol.
- sorbitol is used as the molecular spacer, at a concentration within the range of 0.5 to 10% by weight referred to the weight of water, preferably within the range of 2 to 8% by weight referred to the weight of water, still more preferably at a concentration of 4% by weight referred to the weight of water.
- the aqueous solution includes an ionic polymer, preferably an anionic polymer, and most preferably, carboxymethylcellulose.
- the anionic polymer is carboxymethylcellulose and the polycarboxylic acid is citric acid.
- the aqueous solution includes an ionic polymer and a non-ionic polymer.
- the ionic polymer is preferably an anionic polymer, and most preferably, carboxymethylcellulose.
- the non-ionic polymer is preferably a substituted cellulose, more preferably a hydroxyalkylcellulose or a hydroxyalkyl alkylcellulose, and most preferably hydroxyethylcellulose ("HEC").
- the preferred polycarboxylic acid is citric acid.
- the weight ratios of the ionic and non-ionic polymers can range from about 1:10 to about 10:1, preferably from about 1:5 to about 5:1. In preferred embodiments, the weight ratio is greater than 1:1, for example, from about 2 to about 5.
- the ionic polymer is carboxymethycellulose
- the non-ionic polymer is hydroxyethylcellulose
- the weight ratio (ionic:nonionic) is about 3:1.
- the total precursor concentration in the aqueous solution is of at least 2% by weight referred to the weight of the water of the starting aqueous solution, and the amount of the cross-linking agent is between about 1% and about 5% by weight referred to the weight of the precursor.
- the term "precursor" indicates the hydrophilic polymer(s) used as the precursors for the formation of the polymer hydrogel polymer network, for example, in certain embodiments the "weight of the precursor” is the weight of CMCNa used or the combined weights of CMCNa and HEC used.
- the aqueous solution preferably includes sorbitol in an amount of about 4% by weight relative to the weight of water.
- the cross-linking reaction is preferably carried out at a temperature between about 60°C and 120°C. Varying the temperature during this stage of the process will enable one to increase or decrease the cross-linking degree of the polymer network. A cross-linking temperature of about 80°C is preferred.
- One particularly preferred embodiment of the method of the invention comprises the following steps: Step 1, the hydrophilic polymer(s), the carboxylic acid and, optionally, the molecular spacer are dissolved in water at room temperature; Step 2, the water is removed from the solution at 40°C over a two-day period; Step 3, the product of Step 2 is heated to 80°C for 10 hours to induce the cross-linking reaction and form a polymer hydrogel; Step 4, the polymer hydrogel is washed three times with water over 24 hours; Step 5, the washed polymer hydrogel is immersed in acetone for 24 hours to remove water; Step 6, the polymer hydrogel is further dried in an oven at 45°C for 5 hours; and Step 7, the dried polymer hydrogel is milled to provide polymer hydrogel particles.
- the present invention also provides polymer hydrogels which can be prepared using the methods of the invention.
- Such polymer hydrogels comprise a hydrophilic polymer cross- linked with a polycarboxylic acid selected from C 4 -C 12 -dicarboxylic acids, tricarboxylic acids and tetracarboxylic acids.
- the polymer hydrogels of the invention include at least two hydrophilic polymers cross-linked by a polycarboxylic acid selected from C 4 -C 12 -dicarboxylic acids, tricarboxylic acids and tetracarboxylic acids.
- the polymer hydrogel comprises an ionic polymer and a non-ionic polymer and a polycarboxylic acid selected from a C 4 to C 12 -dicarboxylic acid, a tricarboxylic acid or a tetracarboxylic acid, where the polycarboxylic acid cross-links the ionic polymer and the non-ionic polymer.
- the weight ratio of ionic polymer to non-ionic polymer is preferably from about 1:5 to about 5:1, more preferably from about 2:1 to about 5:1, and most preferably about 3:1.
- the ionic polymer is carboxymethylcellulose
- the non-ionic polymer is hydroxyethylcellulose
- the polycarboxylic acid is citric acid.
- the polymer hydrogel comprises an ionic polymer, for example, an anionic polymer or a cationic polymer. More preferably, the ionic polymer is carboxymethylcellulose or a salt thereof, such as sodium carboxymethylcellulose. In another particularly preferred embodiment, the polymer hydrogel comprises carboxymethylcellulose cross-linked with citric acid.
- the polymer hydrogels of the invention have swelling ratios of at least about 5.
- the polymer hydrogels of the invention are superabsorbent polymer hydrogels, for example, polymer hydrogels having an SR of at least 10.
- the polymer hydrogels of the invention have SRs at least about 20, about 30, about 40, about 50, about 60, about 70, about 80, about 90 or about 100.
- the polymer hydrogels of the invention have SRs from about 10 to about 100, from about 20 to about 100, from about 30 to about 100, from about 40 to about 100, from about 50 to about 100, from about 60 to about 100, from about 70 to about 100, from about 80 to about 100, or from about 90 to about 100.
- the invention includes polymer hydrogels having SRs up to 150, 200, 250, 300, 330 or 350.
- the polymer hydrogels of the invention can absorb an amount of one or more bodily fluids, such as blood, blood plasma, urine, intestinal fluid or gastric fluid, which is at least 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 times their dry weight.
- the ability of the polymer hydrogel to absorb bodily fluids can be tested using conventional means, including testing with samples of bodily fluids obtained from one or more subjects or with simulated bodily fluids, such as simulated urine or gastric fluid.
- the polymer hydrogels can absorb significant amounts of a fluid prepared by combining one volume of simulated gastric fluid (SGF) with eight volumes of water. SGF can be prepared using USP Test Solutions procedures which are known in the art.
- the polymer hydrogels of the invention can absorb at least about 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 or more times their dry weight of this SGF/water mixture.
- the polymer hydrogels of the invention include cross-linked polymers having varying extents of hydration.
- the polymer hydrogels can be provided in a state of hydration ranging from a substantially dry or anhydrous state, such as a state in which from about 0% to about 5% of the polymer hydrogel by weight is water or an aqueous fluid, to states comprising a substantial amount of water or aqueous fluid, including up to a state in which the polymer hydrogel has absorbed a maximum amount of water or an aqueous fluid.
- the polymer hydrogels of the invention can be used in methods for treating obesity, reducing food or calorie intake or achieving or maintaining satiety. Such methods do not form part of the present invention and the following is provided merely by way of background information.
- the methods comprise the step of administering an effective amount of a polymer hydrogel of the invention to the stomach of a subject, preferably by causing the subject, such as a mammal, including a human, to ingest the polymer hydrogel.
- Such polymer hydrogens can be used to take up stomach volume, for example, by increasing the volume of a food bolus without adding to the calorie content of the food.
- the polymer hydrogel can be ingested by the subject prior to eating or in combination with food, for example, as a mixture of the polymer hydrogel with food. Upon ingestion and contact with gastric fluid or a combination of gastric fluid and water, the polymer hydrogel will swell.
- the polymer hydrogel can be ingested alone or in a mixture with liquid or dry food in a dry, partially swollen or fully swollen state, but is preferably ingested in a state of hydration which is significantly below its fluid capacity, more preferably the polymer hydrogel is ingested in an anhydrous state.
- the volume of the stomach taken up by the polymer hydrogel can be significantly greater than the volume of the polymer hydrogel ingested by the subject.
- the polymer hydrogels of the invention can also take up volume and/or exert pressure on the wall of the small intestine by moving from the stomach into the small intestine and swelling.
- the polymer hydrogel will remain swollen in the small intestine for a period of time sufficient to inhibit the intake of food by the subject, before shrinking sufficiently for excretion from the body.
- the time sufficient to inhibit the intake of food by the subject will generally be the time required for the subject to eat and for the ingested food to pass through the small intestine, Such shrinking can occur, for example, by degradation through loss of cross-links, releasing fluid and decreasing in volume sufficiently for excretion from the body.
- Preferred polymers for use in this method exhibit pH-dependent swelling, with greater swelling observed at higher pH than at lower pH.
- a polymer will not swell significantly in the stomach unless food and/or water is present to raise the pH of the stomach contents and will move into the small intestine.
- the polymer hydrogel When ingested with food, the polymer hydrogel will initially swell in the stomach, then shrink when the stomach is emptied of food and the pH drops and then move from the stomach to the small intestine. In the higher pH environment of the small intestine the polymer hydrogel will swell, taking up volume in the small intestine and/or exerting pressure on the wall of the small intestine.
- the polymer hydrogel can optionally be administered in combination with a pH modifying agent, which is an agent which alters the pH of the microenvironment of the polymer hydrogel, thereby modifying its ability to absorb fluids.
- a pH modifying agent which is an agent which alters the pH of the microenvironment of the polymer hydrogel, thereby modifying its ability to absorb fluids.
- agents which increase the pH of the microenvironment can increase the swellability of the polymer hydrogel.
- Suitable pH modifying agents for use with the polymer hydrogels of the invention include buffering agents, H 2 blockers, proton pump inhibitors, anatacids, proteins, nutritional shakes, and combinations thereof.
- Suitable buffering agents and antacids include ammonium bicarbonate, sodium bicarbonate, calcium carbonate, calcium hydroxide, aluminium hydroxide, aluminium carbonate, magnesium carbonate, magnesium hydroxide, potassium bicarbonate, potassium carbonate, potassium hydroxide, sodium carbonate, sodium hydroxide and combinations thereof.
- Suitable H 2 blockers include cimetidine, ranitidine, famotidine, nizatidine and combinations thereof.
- Suitable proton inhibitors include omeprazole, lansoprazole, esorneprazole, pantoprazole, abeprazole, and combinations thereof.
- the present polymer hydrogels can also be used for removing water from the gastrointestinal tract, for example, as a treatment for subjects suffering from kidney disease, including chronic and acute kidney disease, particularly subjects undergoing kidney dialysis.
- the polymer hydrogels can further be used to modify the fluid content in the gastrointestinal tract of a subject in need thereof, for example, for the treatment of constipation.
- the invention further includes articles of manufacture which comprise the polymer hydrogels of the invention.
- articles of manufacture include articles in which polyacrylic polymer hydrogels are conventionally used, in consumer products, such as for example absorbent products for personal care (i.e., babies' napkins, sanitary towels, etc.) and in products for agriculture (e.g., devices for the controlled release of water and nutrients).
- absorbent products for personal care i.e., babies' napkins, sanitary towels, etc.
- products for agriculture e.g., devices for the controlled release of water and nutrients.
- the absorption properties of the polymer hydrogels of the invention which in some embodiments depend on the amount of carboxymethylcellulose employed and which can be improved by the induction of a microporosity in the gel structure, are comparable to those of polyacrylic gels.
- the polymer hydrogels obtainable by the method of the present invention therefore possess mechanical properties which make them suitable for use in all of the above-mentioned fields.
- the present polymer hydrogels have advantages over acrylic polymer hydrogels, such as biodegradability, the absence of any toxic by-products during the manufacturing process and the use of fewer and readily available reagents. Such features enable a real employment of the polymer hydrogels of the invention in the biomedical and pharmaceutical fields as well.
- the polymer hydrogels obtainable by the method of the invention can be used as an absorbent material in products which are capable of absorbing water and/or aqueous solutions and/or which are capable of swelling when brought into contact with water and/or an aqueous solution.
- polymer hydrogels and superabsorbent polymer hydrogels of the present invention may be used as absorbent materials in the following fields, which are provided by way of nonlimiting example:
- the polymer hydrogels of the invention can be used in medicine. Such use includes the use of a polymer hydrogel in the preparation of a medicament for the treatment of obesity or any medical disorder or disease in which calorie restriction has a therapeutic, palliative or prophylactic benefit.
- CMCNa (MW 700 kDa, DS 0.9, food grade), HEC (MW 250kDa, food grade) were purchased from Eigenmann e Veronelli S.p.A. Milano and citric acid was supplied by Dal Cin S.p.A. Sesto San Giovanni Milano and used as received.
- Polymer hydrogel samples were obtained by reacting, in water, CMCNa and HEC with citric acid as a cross-linking agent according the following procedure.
- CMCNa and HEC citric acid as a cross-linking agent
- a total polymer concentration of 2% by weight of water, using a mixture of CMCNa and HEC, with weight ratio equal to 3/1 was dissolved in distilled water by stirring gently at room temperature until a clear solution was obtained.
- Poor cross-linking efficiency has been reported if only CMCNa is used, due both to the electrostatic repulsion between polyelectrolyte chains and to the high degree of substitution of hydroxyl groups at C6, the most reactive position [13].
- CMCNa dissolution is slow at the concentration adopted; thus, first HEC was added to water till, after 5 min, a clear solution was obtained with a slight increase of viscosity; then, CMCNa was added, and the stirring was kept on till a clear solution was obtained (24h), with a significant increase of viscosity. Finally, CA was added at different concentrations (1.75%, 2.75%, 3.75%, 10% and 20% w/w polymer) in order to obtain samples with various degrees of cross-linking. This final solution was used to mold 10 mm thick samples. All samples were first pre-dried at 30°C for 24 h to remove absorbed water and then kept at 80°C for the cross-linking reaction (24h with intermediate control).
- samples containing neat HEC or neat CMCNa samples cross-linked with CA were also prepared following exactly the same experimental conditions used for HEC/CMCNa mixtures.
- a differential scanning calorimeter (Mettler-Toledo 822 e Mettler DSC) was used for thermal analysis.
- the scanning temperature range and the heating rate were 10-200°C and 5°C/min, respectively.
- the adopted thermal cycle was: (1) heating 10-100°C; (2) isotherm at 100°C for 3 minutes; (3) cooling from 100°C to 10°C; (4) heating from 10°C to 200°C; (5) isotherm at 200°C; (6) cooling until room temperature.
- An empty pan was used as a reference.
- FT IR spectra were recorded on a JASCO FT IR 660 plus spectrometer equipped with an attenuated total reflectance (ATR) crystal sampler. Film samples were used directly on a ATR crystal sampler at a resolution of 4 cm -1 , by 300 scans, at absorbance range from 4000 cm -1 to 600 cm -1 .
- ATR attenuated total reflectance
- a DSC thermogram of neat citric acid showed a peak at about 60°C, attributable to a water loss process associated with the dehydration leading to an anhydride.
- CMCNa and HEC powders DSC analysis of neat CMCNa and HEC powders indicates that some water is still absorbed in the polymers. Above 100°C a possible degradation peak of CMCNa is detected. Both CMCNa and HEC show a thermal stability below 100°C.
- a film of polymer hydrogel obtained using a 3:1 ratio of CMCNa/HEC and 3.75% by weight of polymer of citric acid was analyzed by DSC after drying the sample at 30°C for 24 h and then reduced to powder.
- a large endothermic peak associated to the evaporation of the water produced by the anhydrification process is evident.
- a small exothermic peak, attributed to esterification is superimposed on the first one.
- T g 38°C
- FT IR spectra were recorded of citric acid, of the A10 reaction mixture before heating and of the A10 reaction mixture after 5 h of heating.
- the FT IR spectrum of sample A10 shows a strong absorption band at 1590 cm -1 characteristic of cellulose [16]. After heating, the absorbance band at about 1590cm -1 is still observed and additionally a new band at 1738 cm -1 appears.
- Anhydrides display two stretching bands in the carbonyl region around 1758 cm -1 and 1828 cm -1 .
- the new peak observed at 1738 cm -1 can be attributed to the characteristic stretching band of the carbonyl group at lower frequency related to anhydride formation, an intermediate reaction necessary for reaction of CA with cellulose hydroxyl groups. In contrast, the carbonyl peak expected at higher frequency is not detectable probably due to its weak intensity.
- FT IR spectra were recorded of citric acid, B10 reaction mixture before heating and B10 reaction mixture after 6.5 h of heating.
- the HEC spectrum again shows the band at 1590 cm -1 before and after heating while the absorbance of the carbonyl group at 1738 cm -1 appears only after heating at 80°C as observed for the sample A10.
- FTIR spectra were also recorded for reactions of HEC polymer when the reaction is performed at 80°C with either 20% CA or 10% CA.
- the anhydride band intensity increases from 0 to 0.098 when the reaction time increase from 0 h to 6.5 h, but drops to 0 when the reaction time reaches 24 h.
- the 20% CA reaction follows exactly the same trend providing a maximum value of 0.079 at 5h.
- the cross-linking mechanism is the same as described for CMCNa
- the anhydrification and esterification reactions appear superimposed in this case. Therefore, in the FTIR spectra, the HEC polymer shows a single peak. This latter result was in accordance with conclusion of Xie and co-workers [18]. They studied the degree of substitution, as evaluation of cross-linking esterification, on starch thermally reacted with CA at different reaction time and found a maximum after a few hours.
- CMCNa has carboxylic acid functional groups in its structure that increase the volume variation process in solution. A preliminary attempt to follow the reaction pathway failed.
- reaction sample C20 shows similar spectra.
- polymer mixtures C10 and C20
- a broad signal appears at about 1715 cm -1 , especially when a higher CA concentration is used in the reaction.
- the signal of CA at 1715 cm -1 is very broad and overlapped to the polymer signal at 1590 cm -1 then a clear band is not detectable.
- the C10 reaction mixture before heating shows a band around 1715 cm -1 covering the absorbance region monitored previously for the other reactions (A10, A20, B10, B20); consequently a clear assignment to the carbonyl group is difficult.
- the other two spectra indicate that this band moves to higher wavenumbers during the cross-linking reaction.
- the FT IR spectrum shows a broad band in the range of 1711 cm -1 - 1736 cm -1 and after 13h this band appears more clearly as a narrow absorbance band at 1737 cm -1 , which is typical of carbonyl groups.
- Spectra of C20 reaction provide similar results. Although a quantitative analysis of carbonyl groups is not possible when C10 and C20 samples are cross-linked, an evaluation of the carbonyl peak similar to those observed for the reaction of the neat polymers can be assumed.
- the cross-linking kinetics were also monitored studying the swelling behaviour during the reaction progress. Swelling ratio was calculated as a function of the reaction time for: (a) CMCNa with 10% or 20% of CA concentration; (b) HEC with 10% or 20% of CA concentration; (c) the mixture of CMCNa and HEC (3/1) with 10% or 20% CA concentration; (d) the mixture of CMCNa and HEC (3/1) with 1.75%, 2.75% or 3.75% CA concentration.
- CMCNa/CA sample The maximum swelling of CMCNa/CA sample is observed at the gelation onset, after 3 h, when the second esterification reaction, those leading to cross-linking, begins. Then as the cross-linking process increases the corresponding equilibrium water sorption decreases, confirming the results of FTIR analysis.
- Polymer hydrogels of practical use presenting a high degree of swelling were obtained with a reduced concentration of citric acid (1.75%, 2.75%, 3.75% by weight of polymer). With a citric acid concentration of 3.75% the swelling ratio can reach 900.
- This polymer hydrogel, after swelling, is characterized by adequate stiffness and it is able to keep the same shape of the synthesis vat.
- Polymer hydrogels formerly synthesized [13] using divinyl sulfone, a toxic reagent, as cross-linking agents and the same ratio between CMCNa and HEC were characterized by a maximum swelling ratio of 200. In this case a higher swelling ratio is obtained using an environmentally friendly cross-linking agent. At concentrations lower than 1.75% CA, a weak cross-linking associated with insufficient mechanical property is observed.
- the cross-linking reaction for CMCNa/HEC system was observed either by DSC or by FTIR analysis.
- the evolution of the different cross-linking reactions was monitored by means of FT IR spectra collected at different reaction times using an excess of citric acid.
- An optimal degree of swelling (900) for practical applications was achieved using low CA concentrations.
- the polymer hydrogel obtained through the method described in this Example 1 has the great advantage to reduce primary and production costs and avoid any toxic intermediate during its synthetic process.
- the polymer hydrogels were prepared by cross-linking an aqueous solution of carboxymethylcellulose sodium salt (CMCNa) and hydroxyethylcellulose (HEC), using citric acid (CA) as the cross-linking agent and sorbitol as the molecular spacer.
- CMCNa carboxymethylcellulose sodium salt
- HEC hydroxyethylcellulose
- CA citric acid
- sorbitol the molecular spacer.
- the composition of a gel is given by the nominal amount of the reagents in the starting solution.
- CMCNa is the ionic polymer species, it is possible to achieve the desired absorption properties adjusting the weight ratio of carboxymethylcellulose sodium salt (CMCNa) to hydroxyethylcellulose (HEC).
- CMCNa/HEC weight ratio of between 0/1 and 5/1, preferably between 1/1 and 3/1, was observed to enable the synthesis of a polymer hydrogel having optimum absorption properties.
- Preparation of polymer hydrogel A in a beaker containing distilled water, sorbitol at a concentration of 4% by weight referred to the weight of distilled water was added and mixed until complete solubilisation, which occured within a few minutes.
- the CMCNa and HEC polymers are added at a total concentration of 2% by weight referred to the weight of distilled water, with a CMCNa/HEC weight ratio of 3/1. Mixing proceeded until solubilisation of the whole quantity of polymer is achieved and the solution became clear.
- citric acid at a concentration of 1% by weight referred to the weight of the precursor was added to the solution, whose viscosity had greatly increased.
- the solution thereby obtained was poured into a vessel and dried at 48°C for 48 hours.
- the macromolecules are stabilised into a polymeric network which is the backbone of the polymer hydrogel.
- the polymer hydrogel was washed with distilled water for 24 hours at room temperature.
- the polymer hydrogel swelled up thereby eliminating the impurities.
- at least 3 rinses with distilled water were performed during the 24 hours washing step.
- the polymer hydrogel was dried by phase inversion in acetone as the nonsolvent, until a glassy white precipitate is obtained. The precipitate is then placed into an oven at 45°C for about 3 hours, to remove any residual trace of acetone.
- Polymer hydrogel B was prepared as polymer hydrogel A, with the only exception that the polymer is made only of CMCNa, and that the CMCNa concentration is 2% by weight referred to the weight of distilled water.
- Polymer hydrogel C was prepared as polymer hydrogel B, with the only exception that the citric acid concentration is 2% by weight referred to the weight of CMCNa.
- Polymer hydrogel D was prepared as polymer hydrogel B, with the only exception that the citric acid concentration is 0.5% by weight referred to the weight of CMCNa.
- the absorption measurements essentially consist of placing the dry sample, obtained from the drying step, in distilled water, so that it swells up until an equilibrium condition is reached.
- the absorption properties of the gel are assessed based on its swelling ratio (SR), defined according to the formula illustrated above.
- SR swelling ratio
- Table 2 below reports some of the results obtained, in terms of the swelling ratio, varying the concentrations of the reagents and the cross-linking times (6 hours, 13 hours, 18 hours, 24 hours).
- Table 3 shows that the sample having the best swelling ratio is the sample designated as g22, which is characterised by a citric acid (CA) concentration of 1%.
- CA citric acid
- Table 4 shows some of the results obtained.
- the highest swelling ratio is associated with a cross-linking time of 13 hours and a citric acid concentration of 1%. It is also to be noticed that higher citric acid concentrations together with shorter cross-linking times lead to equally satisfactory swelling ratios, although the reaction is very fast and less easy to control.
- the possibility of increasing the swelling ratio by creating porosity into the material which could promote the absorbing properties was evaluated.
- the sample g31 subjected to cross-linking for 12 hours, was swelled into distilled water for 24 hours and then dried by phase inversion in acetone. With this technique, a swelling ratio of 200 was obtained.
- This example describes an evaluation of the superabsorbent polymer hydrogel denoted polymer hydrogel B in Example 2 in in vitro swelling and collapsing experiments in various media at 37°C.
- SGF simulated gastric fluid
- SGF was prepared according to USP Test Solutions procedures. The swelling ratio in each fluid was determined at various time points. The results are set forth in Tables 5 and 6. Table 5.
- This polymer hydrogel swells in simulated gastric fluids (pH 1.5) approximately 15 fold, and in a simulated gastric fluids/water mixture (pH 3) approximately 85 fold. This indicates that the polymer hydrogel has a pH/swelling correlation where at pH below 3 (pKa of CMC is ⁇ 3.1) there will be limited swelling of the polymer hydrogel due to absence of the Donnan effect.
- the polymer can also swell in the increased pH of simulated intestinal fluid.
- Figure 2 a graph of cumulative food intake as a function of time, represents a typical study result. There was no difference between the groups at base line. Gavage of 8 mL of polymer hydrogel B induced satiety in the rats that led to a significant decrease in food intake. As shown in the yellow line, this polymer hydrogel induced a marked decrease in food intake that persisted over 2 hours. These data suggest that polymer hydrogel B can induce satiety in animals and leads to a decrease in food intake.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Biological Depolymerization Polymers (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Colloid Chemistry (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Description
- The present invention relates to polymer hydrogels and methods of preparation thereof.
- Polymer hydrogels are cross-linked hydrophilic polymers which are capable of absorbing high amounts of water. In particular, cross-linked polymer hydrogels capable of absorbing an amount of water in excess of 10 times their dry weight are defined as "superabsorbent". Some of these materials are even capable of absorbing over 1 litre of water per gram of dry polymer.
- The cross-links or cross-linking knots, i.e. the physical or chemical bonds between the macromolecular chains forming the polymer hydrogel network, guarantee the structural integrity of the polymer-liquid system, on the one hand preventing the complete solubilisation of the polymer, and on the other hand allowing the retention of the aqueous phase within the molecular mesh.
- The superabsorbent polymer hydrogels which are currently available on the market are characterised not only by their marked absorbent properties, but also by their biocompatibility, which is probably due to the high water content, and, above all, by the possibility of adjusting their absorption properties according to the external stimuli. Consequently, such polymer hydrogels may be used as intelligent materials, for example for the manufacture of sensors or actuators for a number of industrial applications. Besides the usual applications as absorbent cores in the field of personal hygiene absorbent products, there are more recent and innovative applications such as for example in the biomedical field, for the development of controlled release drug formulations, artificial muscles, sensors, etc., and in agriculture and horticulture, for example in devices for the controlled release of water and nutrients in arid soils.
- However, the superabsorbent polymer hydrogels currently available are almost exclusively acrylic-based products, and hence not biodegradable.
- Given the growing interest in environmental protection issues, over recent years a vast amount of interest has been focussed on the development of superabsorbent materials based on biodegradable polymers, having properties which are similar to those of the traditional superabsorbent polyacrylics.
- Examples of biodegradable polymers used to obtain superabsorbent polymer hydrogels are starch and cellulose derivatives.
- In 1990 Anbergen and Oppermann [1] proposed a method for the synthesis of a superabsorbent material made entirely from cellulose derivatives. In particular, they used hydroxyethylcellulose (HEC) and a carboxymethylcellulose sodium salt (CMCNa), chemically cross-linked in a basic solution with divinylsulphone. However, the absorption properties of such materials are not high compared to those of the acrylic-based superabsorbent materials.
- In 1996 Esposito and co-workers [2], studying the synthetic process proposed by Anbergen and Opperman, developed a method for increasing the absorption properties of the gel, acting mainly on the physical properties of the material. The basic idea was the induction of microporosity into the polymer structure, so as to promote absorption and retention of water by capillarity. Said microporosity was induced during the drying step, which was carried out by phase inversion in a nonsolvent for the polymer, and the absorption properties of the material thus obtained were markedly superior to those of the air-dried gel.
- CMCNa may be chemically cross-linked with any reagent which is bifunctional with respect to cellulose. Besides the divinylsulphone used in the synthetic process according to Anbergen and Opperman, epichlorhydrin, formaldehyde and various diepoxides have also been used as cross-linking agents. However, such compounds are highly toxic in their unreacted states [3]. Some carbodiimides are known amongst the unconventional cross-linking agents. Particularly, the use of carbodiimides in order to cross-link salified or non-salified carboxymethylcellulose (CMC) was described in [4]. Carbodiimides induce the formation of ester bonds between cellulose macromolecules without participating in the bonds themselves, instead giving rise to a urea derivative having very low toxicity [5]. A superabsorbent polymer hydrogel obtained by cross-linking carboxymethylcellulose sodium salt and hydroxyethylcellulose with carbodiimide as the cross-linking agent is disclosed in the international patent application
WO 2006/070337 [6]. - However, the carbodiimide used as a cross-linking agent in
WO 2006/070337 has the disadvantage of being extremely expensive. Moreover, during the cross-linking reaction with CMCNa, this substance turns into a slightly toxic urea derivative, which must be removed during the washing step, thereby further increasing the costs and the complexity of the production process. These drawbacks are extremely unfavourable, particularly in connection with those applications which require large scale production of the polymer hydrogels and which, consequently, involve high costs both with respect to the purchase of the starting materials and with respect to the disposal of the toxic substances which are produced during synthesis. - Furthermore, the formation of substances having a certain degree of toxicity, although very low, is a key factor for ruling out the possibility of using such polymers in biomedical and pharmaceutical applications.
-
WO 96/02276 - The object of the present invention is to provide polymer hydrogels which overcome the above-mentioned disadvantages associated with the use of carbodiimide as a cross-linking agent.
- These and other objects are achieved by the polymer hydrogels of the invention and the method of preparation thereof as defined herein. The polymer hydrogels of the invention are based on the use of a polycarboxylic acid, such as citric acid, as the cross-linking agent, and in preferred embodiments, also include the use of a molecular spacer.
- The invention relates, in part, to the discovery that the cross-linking of soluble cellulose derivatives with citric acid (3-carboxy-3-hydroxy-1,5-pentanedioic acid; hereinafter designated "CA") results in the formation of polymer hydrogels and superabsorbent polymer hydrogels. CA is naturally occurring, non-toxic and available on the market at low cost. Although CA has been reported as a cross-linking agent for polymers such as cellulose, hydroxypropylmethylcellulose and starch, in textile and food applications [7-11], in these applications CA is used to cross-link and further stabilize insoluble fibers, to provide a fabric with enhanced resiliency and mechanical properties. However, the use of CA to cross-link carboxymethylcellulose or other soluble hydrophilic polymers for preparing polymer hydrogels and superabsorbent polymer hydrogels has not been previously disclosed.
- One aspect of the present invention provides a method of preparing a polymer hydrogel comprising the steps of (a) preparing an aqueous solution comprising one or more hydrophilic polymers, a polycarboxylic acid selected from C4-C12-dicarboxylic acids, tricarboxylic acids and tetracarboxylic acids and a polyhydroxylated compound selected from plant glycerol, monosaccharides, disaccharides and sugar alcohols; and (b) heating the aqueous solution to remove water and cross-link the one or more hydrophilic polymers, thereby forming a polymer hydrogel.
- In one embodiment, the aqueous solution comprises two or more hydrophilic polymers, such as, for example, hydroxylated polymers. For example, the aqueous solution can comprise a first hydrophilic polymer and a second hydrophilic polymer, which can be present in the same or different amounts on a weight basis. In one embodiment, the first hydrophilic polymer is an ionic polymer and the second polymer is a nonionic polymer.
- Also described is a method for preparing a polymer hydrogel, comprising the steps of (a) providing an aqueous solution of carboxymethylcellulose, hydroxyethylcellulose, citric acid and a molecular spacer; (b) heating the aqueous solution, thereby evaporating the water and cross-linking the carboxymethylcellulose and hydroxyethylcellulose to form a polymer hydrogel material; (c) washing the polymer hydrogel material with water or a polar organic solvent to form a washed polymer hydrogel; (d) immersing the washed polymer hydrogel in a cellulose nonsolvent, thereby producing a dried polymer hydrogel;
- A second aspect of the present invention provides a method of producing a polymer hydrogel comprising the steps of (a) preparing an aqueous solution of carboxymethylcellulose, preferably carboxymethylcellulose sodium salt, and citric acid: (b) heating the aqueous solution to remove water and cross-link the carboxymethylcellulose, thereby forming a polymer hydrogel; (c) washing the polymer hydrogel with water, a polar organic solvent or a combination thereof, thereby producing a washed polymer hydrogel; and (d) drying the washed polymer hydrogel by immersing the washed polymer hydrogel in a cellulose nonsolvent, thereby producing the polymer hydrogel.
- A third aspect of the present invention provides polymer hydrogels, such as superabsorbent polymer hydrogels, which can be prepared using the methods of the invention. Such polymer hydrogels comprise at least one hydrophilic polymer cross-linked with a polycarboxylic acid. A fourth aspect of the present invention provides articles of manufacture which comprise such polymer hydrogels.
-
-
Figure 1 illustrates the proposed mechanism of polymer cross-linking by citric acid. -
Figure 2 is a graph of cumulative food intake as a function of time for rats administered a polymer hydrogel of the invention orally and rats administered vehicle only. - The present invention provides polymer hydrogels, methods of preparing the polymer hydrogels, and articles of manufacture comprising the polymer hydrogels.
- The methods of preparing a polymer hydrogel of the present invention comprise the step of cross-linking an aqueous solution comprising a hydrophilic polymer with a polycarboxylic acid, thereby producing the polymer hydrogel. In some embodiments, the aqueous solution comprises two or more hydrophilic polymers. For example, the aqueous solution can comprise a first hydrophilic polymer and a second hydrophilic polymer, which can be present in the same or different amounts on a weight basis. In preferred embodiments, the first hydrophilic polymer is an ionic polymer and the second polymer is a nonionic polymer.
- The cross-linking reaction is preferably conducted at elevated temperature, for example, at a temperature greater than room temperature (25°C). For example, the reaction can be conducted at a temperature from about 30°C to about 150°C, preferably from about 50°C to about 120°C. In one embodiment, while the cross-linking reaction is conducted at elevated temperature, the reaction solution is concentrated by removal of water. The removal of water can be accomplished, for example, by evaporation. In one embodiment, a fraction of the water is removed. In another embodiment, substantially all of the water is removed, thereby producing a dry residue. Optionally, the reaction mixture is maintained at elevated temperature for a period of time following removal of water to dryness.
- As used herein, the term "hydrophilic polymer" refers to a polymer which is substantially water-soluble and, preferably, includes monomeric units which are hydroxylated. A hydrophilic polymer can be a homopolymer, which includes only one repeating monomeric unit, or a copolymer, comprising two or more different repeating monomeric units. In a preferred embodiment, the hydrophilic polymer is hydroxylated, such as polyallyl alcohol, polyvinyl alcohol or a polysaccharide. Examples of suitable polysaccharides include substituted celluloses, substituted dextrans, starches and substituted starches, glycosaminoglycans, chitosan and alginates.
- Polysaccharides which can be used include alkylcelluloses, such as C1-C6-alkylcelluloses, including methylcellulose, ethylcellulose and n-propylcellulose; substituted alkylcelluloses, including hydroxy-C1-C6-alkylcelluloses and hydroxy-C1-C6-alkyl-C1-C6-alkylcelluloses, such as hydroxyethylcellulose, hydroxy-n-propylcellulose, hydroxy-n-butylcellulose, hydroxypropylmethylcellulose, ethylhydroxyethylcellulose and carboxymethylcellulose; starches, such as corn starch, hydroxypropylstarch and carboxymethylstarch; substituted dextrans, such as dextran sulfate, dextran phosphate and diethylaminodextran; glycosaminoglycans, including heparin, hyaluronan, chondroitin, chondroitin sulfate and heparan sulfate; and polyuronic acids, such as polyglucuronic acid, polymanuronic acid, polygalacturonic acid and polyarabinic acid.
- As used herein, the term "ionic polymer" refers to a polymer comprising monomeric units having an acidic functional group, such as a carboxyl, sulfate, sulfonate, phosphate or phosphonate group, or a basic functional group, such as an amino, substituted amino or guanidyl group. When in aqueous solution at a suitable pH range, an ionic polymer comprising acidic functional groups will be a polyanion, and such a polymer is referred to herein as an "anionic polymer". Likewise, in aqueous solution at a suitable pH range, an ionic polymer comprising basic functional groups will be a polycation. Such a polymer is referred to herein as an "cationic polymer". As used herein, the terms ionic polymer, anionic polymer and cationic polymer refer to hydrophilic polymers in which the acidic or basic functional groups are not charged, as well as polymers in which some or all of the acidic or basic functional groups are charged, in combination with a suitable counterion. Suitable anionic polymers include alginate, dextran sulfate, carboxymethylcellulose, hyaluronic acid, polyglucuronic acid, polymanuronic acid, polygalacturonic acid, polyarabinic acid; chrondroitin sulfate and dextran phosphate. Suitable cationic polymers include chitosan and dimethylaminodextran. A preferred ionic polymer is carboxymethylcellulose, which can be used in the acid form, or as a salt with a suitable cation, such as sodium or potassium.
- The term "nonionic polymer", as used herein, refers to a hydrophilic polymer which does not comprise monomeric units having ionizable functional groups, such as acidic or basic groups. Such a polymer will be uncharged in aqueous solution. Examples of suitable nonionic polymers for use in the present method are polyallylalcohol, polyvinylalcohol, starches, such as corn starch and hydroxypropylstarch, alkylcelluloses, such as C1-C6-alkylcelluloses, including methylcellulose, ethylcellulose and n-propylcellulose; substituted alkylcelluloses, including hydroxy-C1-C6-alkylcelluloses and hydroxy-C1-C6-alkyl-C1-C6-alkylcelluloses, such as hydroxyethylcellulose, hydroxy-n-propylcellulose, hydroxy-n-butylcellulose, hydroxypropylmethylcellulose, and ethylhydroxyethylcellulose.
- As used herein, the term "polycarboxylic acid" refers to an organic acid having two or more carboxylic acid functional groups, such as dicarboxylic acids, tricarboxylic acids and tetracarboxylic acids, aand also includes the anhydride forms of such organic acids. Dicarboxylic acids include oxalic acid, malonic acid, maleic acid, malic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, phthalic acid, o-phthalic acid, isophthalic acid, m-phthalic acid, and terephthalic acid. Preferred dicarboxylic acids include C4-C12- dicarboxylic acids. Suitable tricarboxylic acids include citric acid, isocitric acid, aconitic acid, and propane-1,2,3-tricarboxylic acid. Suitable tetracarboxylic acids include pyromellitic acid, 2,3,3',4'-biphenyltetracarboxylic acid, 3,3',4,4'-tetracarboxydiphenylether, 2,3',3,4'-tetracarboxydiphenylether, 3,3',4,4'-benzophenonetetracarboxylic acid, 2,3,6,7-tetracarboxynaphthalene, 1,4,5,7-tetracarboxynaphthalene, 1,4,5,6-tetracarboxynaphthalene, 3,3',4,4'-tetracarboxydiphenylmethane, 2,2-bis(3,4-dicarboxyphenyl)propane, butanetetracarboxylic acid, and cyclopentanetetracarboxylic acid. A particularly preferred polycarboxylic acid is citric acid.
- The method can further include the steps of purifying the polymer hydrogel, for example, by washing the polymer hydrogel in a polar solvent, such as water, a polar organic solvent, for example, an alcohol, such as methanol or ethanol, or a combination thereof. The polymer hydrogel immersed in the polar solvent swells and releases any component, such as by-products or unreacted polycarboxylic acid, that was not incorporated into the polymer network. Water is preferred as the polar solvent, distilled water is still more preferred. The volume of water required during this step to reach the maximum swelling degree of the gel, is approximately 10- to 20-fold greater than the initial volume of the gel itself. Taking into account the substantial amounts of water which would be involved during this step on an industrial scale, as well as the disposal and/or recycling of the washes, the importance of avoiding the presence of any toxic by-products in the synthetic process becomes evident. The polymer hydrogel washing step may be repeated more than once, optionally changing the polar solvent employed. For example, the polymer hydrogel can be washed with methanol or ethanol followed by distilled water, with these two steps optionally repeated one or more times.
- The method can further include drying of the polymer hydrogel. The drying step is carried out by immersing the fully swollen polymer hydrogel in a cellulose nonsolvent, a process known as phase inversion. Suitable cellulose nonsolvents include, for example, acetone and ethanol. Drying the polymer hydrogel by phase inversion results in a final microporous structure which improves the absorption properties of the polymer hydrogel by capillarity. Moreover, if the porosity is interconnected or open, i.e. the micropores communicate with one another, the absorption/desorption kinetics of the gel will be improved as well. When a completely or partially swollen gel is immersed into a nonsolvent, the gel undergoes phase inversion with the expulsion of water, until the gel precipitates in the form of a vitreous solid as white coloured particles. Various rinses in the nonsolvent may be necessary in order to obtain the dried gel in a short period of time. For example, when the swollen polymer hydrogel is immersed in acetone as the non-solvent, a water/acetone mixture is formed which increases in water content as the polymer hydrogel dries; at a certain acetone/water concentration, for example, about 55% in acetone, water is no longer able to exit from the polymer hydrogel, and thus fresh acetone has to be added to the polymer hydrogel to proceed with the drying process. The higher the acetone/water ratio during drying, the faster is the drying process. Pore dimensions are affected by the rate of the drying process and the initial dimensions of the polymer hydrogel particles: larger particles and a faster process tend to increase the pore dimensions; pore dimensions in the microscale range are preferred, as pores in this size range exhibit a strong capillary effect, resulting in the higher sorption and water retention capacity.
- The polymer hydrogels of the invention can also be dried by another process, such as air drying, freeze drying or oven drying. These drying methods can be used alone, in combination, or in combination with the non-solvent drying step described above. For example, the polymer hydrogel can be dried in a non-solvent, followed by air drying, freeze drying, oven drying, o a combination thereof to eliminate any residual traces of nonsolvent. Oven drying can be carried out at a temperature of e.g. approximately 30-45°C until the residual nonsolvent is completely removed. The washed and dried polymer hydrogel can then be used as is, or can be milled to produce polymer hydrogel particles of a desired size.
- The cross-linking solution can optionally include a compound which serves as a molecular spacer. A "molecular spacer", as this term is used herein, is a polyhydroxylated compound which, although not taking part in the reaction resulting in the formation of the cross-linked polymer hydrogel network to a significant extent, results in a polymer hydrogel with an increased absorption capacity. Although in certain cases the molecular spacer may participate in the cross-linking reaction to a small extent, it is believed that molecular spacers function by sterically blocking access to the polymer chains, thereby increasing the average distance between the polymer chains. Cross-linking, therefore, can occur at sites which are not close together, thereby enhancing the ability of the polymer network to expand so as to greatly increase the polymer hydrogel absorption properties. Suitable compounds for use as molecular spacers in the methods of the present invention include monosaccharides, disaccharides and sugar alcohols, including sucrose, sorbitol, plant glycerol, mannitol, trehalose, lactose, maltose, erythritol, xylitol, lactitol, maltitol, arabitol, glycerol, isomalt and cellobiose. The molecular spacer is preferably included in the cross-linking solution in the amount of about 0.5% to about 10% by weight relative to the solvent, more preferably about 2% to about 8% and more preferably about 4%.
- According to a preferred embodiment of the invention, the molecular spacer used to synthesise the polymer hydrogel is selected from the group consisting of sorbitol, sucrose and plant glycerol.
- According to a particularly preferred embodiment of the method of the invention, sorbitol is used as the molecular spacer, at a concentration within the range of 0.5 to 10% by weight referred to the weight of water, preferably within the range of 2 to 8% by weight referred to the weight of water, still more preferably at a concentration of 4% by weight referred to the weight of water.
- In one embodiment, the aqueous solution includes an ionic polymer, preferably an anionic polymer, and most preferably, carboxymethylcellulose. In a particularly preferred embodiment the anionic polymer is carboxymethylcellulose and the polycarboxylic acid is citric acid.
- In another embodiment, the aqueous solution includes an ionic polymer and a non-ionic polymer. The ionic polymer is preferably an anionic polymer, and most preferably, carboxymethylcellulose. The non-ionic polymer is preferably a substituted cellulose, more preferably a hydroxyalkylcellulose or a hydroxyalkyl alkylcellulose, and most preferably hydroxyethylcellulose ("HEC"). The preferred polycarboxylic acid is citric acid.
- The weight ratios of the ionic and non-ionic polymers (ionic:non-ionic) can range from about 1:10 to about 10:1, preferably from about 1:5 to about 5:1. In preferred embodiments, the weight ratio is greater than 1:1, for example, from about 2 to about 5. In a particularly preferred embodiment, the ionic polymer is carboxymethycellulose, the non-ionic polymer is hydroxyethylcellulose, and the weight ratio (ionic:nonionic) is about 3:1.
- In a preferred embodiment of the method of the invention, which results in the formation of superabsorbent polymer hydrogels having a particularly high swelling ratio (SR), the total precursor concentration in the aqueous solution is of at least 2% by weight referred to the weight of the water of the starting aqueous solution, and the amount of the cross-linking agent is between about 1% and about 5% by weight referred to the weight of the precursor. In the present description, the term "precursor" indicates the hydrophilic polymer(s) used as the precursors for the formation of the polymer hydrogel polymer network, for example, in certain embodiments the "weight of the precursor" is the weight of CMCNa used or the combined weights of CMCNa and HEC used. The aqueous solution preferably includes sorbitol in an amount of about 4% by weight relative to the weight of water.
- The swelling ratio (SR) is a measure of the ability of the polymer hydrogel to absorb water. SR is obtained through swelling measurements at the equilibrium (using, for example, a Sartorius micro scale with a sensitivity of 10-5) and it is calculated with the following formula:
- According to the preparation method of the invention, in this embodiment, the cross-linking reaction is preferably carried out at a temperature between about 60°C and 120°C. Varying the temperature during this stage of the process will enable one to increase or decrease the cross-linking degree of the polymer network. A cross-linking temperature of about 80°C is preferred.
- One particularly preferred embodiment of the method of the invention comprises the following steps: Step 1, the hydrophilic polymer(s), the carboxylic acid and, optionally, the molecular spacer are dissolved in water at room temperature; Step 2, the water is removed from the solution at 40°C over a two-day period; Step 3, the product of Step 2 is heated to 80°C for 10 hours to induce the cross-linking reaction and form a polymer hydrogel; Step 4, the polymer hydrogel is washed three times with water over 24 hours; Step 5, the washed polymer hydrogel is immersed in acetone for 24 hours to remove water; Step 6, the polymer hydrogel is further dried in an oven at 45°C for 5 hours; and Step 7, the dried polymer hydrogel is milled to provide polymer hydrogel particles.
- The present invention also provides polymer hydrogels which can be prepared using the methods of the invention. Such polymer hydrogels comprise a hydrophilic polymer cross- linked with a polycarboxylic acid selected from C4-C12-dicarboxylic acids, tricarboxylic acids and tetracarboxylic acids. In other embodiments, the polymer hydrogels of the invention include at least two hydrophilic polymers cross-linked by a polycarboxylic acid selected from C4-C12-dicarboxylic acids, tricarboxylic acids and tetracarboxylic acids. In one preferred embodiment, the polymer hydrogel comprises an ionic polymer and a non-ionic polymer and a polycarboxylic acid selected from a C4 to C12-dicarboxylic acid, a tricarboxylic acid or a tetracarboxylic acid, where the polycarboxylic acid cross-links the ionic polymer and the non-ionic polymer. The weight ratio of ionic polymer to non-ionic polymer is preferably from about 1:5 to about 5:1, more preferably from about 2:1 to about 5:1, and most preferably about 3:1. In one particularly preferred embodiment, the ionic polymer is carboxymethylcellulose, the non-ionic polymer is hydroxyethylcellulose and the polycarboxylic acid is citric acid. In another preferred embodiment, the polymer hydrogel comprises an ionic polymer, for example, an anionic polymer or a cationic polymer. More preferably, the ionic polymer is carboxymethylcellulose or a salt thereof, such as sodium carboxymethylcellulose. In another particularly preferred embodiment, the polymer hydrogel comprises carboxymethylcellulose cross-linked with citric acid.
- The polymer hydrogels of the invention have swelling ratios of at least about 5. Preferably, the polymer hydrogels of the invention are superabsorbent polymer hydrogels, for example, polymer hydrogels having an SR of at least 10. In preferred embodiments, the polymer hydrogels of the invention have SRs at least about 20, about 30, about 40, about 50, about 60, about 70, about 80, about 90 or about 100. For example, in certain embodiments, the polymer hydrogels of the invention have SRs from about 10 to about 100, from about 20 to about 100, from about 30 to about 100, from about 40 to about 100, from about 50 to about 100, from about 60 to about 100, from about 70 to about 100, from about 80 to about 100, or from about 90 to about 100. In certain embodiments, the invention includes polymer hydrogels having SRs up to 150, 200, 250, 300, 330 or 350.
- In certain embodiments, the polymer hydrogels of the invention can absorb an amount of one or more bodily fluids, such as blood, blood plasma, urine, intestinal fluid or gastric fluid, which is at least 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 times their dry weight. The ability of the polymer hydrogel to absorb bodily fluids can be tested using conventional means, including testing with samples of bodily fluids obtained from one or more subjects or with simulated bodily fluids, such as simulated urine or gastric fluid. In certain preferred embodiments, the polymer hydrogels can absorb significant amounts of a fluid prepared by combining one volume of simulated gastric fluid (SGF) with eight volumes of water. SGF can be prepared using USP Test Solutions procedures which are known in the art. In some embodiments, the polymer hydrogels of the invention can absorb at least about 10, 20, 30, 40, 50, 60, 70, 80, 90, 100 or more times their dry weight of this SGF/water mixture.
- The polymer hydrogels of the invention include cross-linked polymers having varying extents of hydration. For example, the polymer hydrogels can be provided in a state of hydration ranging from a substantially dry or anhydrous state, such as a state in which from about 0% to about 5% of the polymer hydrogel by weight is water or an aqueous fluid, to states comprising a substantial amount of water or aqueous fluid, including up to a state in which the polymer hydrogel has absorbed a maximum amount of water or an aqueous fluid.
- The polymer hydrogels of the invention can be used in methods for treating obesity, reducing food or calorie intake or achieving or maintaining satiety. Such methods do not form part of the present invention and the following is provided merely by way of background information. The methods comprise the step of administering an effective amount of a polymer hydrogel of the invention to the stomach of a subject, preferably by causing the subject, such as a mammal, including a human, to ingest the polymer hydrogel. Such polymer hydrogens can be used to take up stomach volume, for example, by increasing the volume of a food bolus without adding to the calorie content of the food. The polymer hydrogel can be ingested by the subject prior to eating or in combination with food, for example, as a mixture of the polymer hydrogel with food. Upon ingestion and contact with gastric fluid or a combination of gastric fluid and water, the polymer hydrogel will swell. The polymer hydrogel can be ingested alone or in a mixture with liquid or dry food in a dry, partially swollen or fully swollen state, but is preferably ingested in a state of hydration which is significantly below its fluid capacity, more preferably the polymer hydrogel is ingested in an anhydrous state. Thus, the volume of the stomach taken up by the polymer hydrogel can be significantly greater than the volume of the polymer hydrogel ingested by the subject. The polymer hydrogels of the invention can also take up volume and/or exert pressure on the wall of the small intestine by moving from the stomach into the small intestine and swelling. Preferably, the polymer hydrogel will remain swollen in the small intestine for a period of time sufficient to inhibit the intake of food by the subject, before shrinking sufficiently for excretion from the body. The time sufficient to inhibit the intake of food by the subject will generally be the time required for the subject to eat and for the ingested food to pass through the small intestine, Such shrinking can occur, for example, by degradation through loss of cross-links, releasing fluid and decreasing in volume sufficiently for excretion from the body. Preferred polymers for use in this method exhibit pH-dependent swelling, with greater swelling observed at higher pH than at lower pH. Thus, such a polymer will not swell significantly in the stomach unless food and/or water is present to raise the pH of the stomach contents and will move into the small intestine. When ingested with food, the polymer hydrogel will initially swell in the stomach, then shrink when the stomach is emptied of food and the pH drops and then move from the stomach to the small intestine. In the higher pH environment of the small intestine the polymer hydrogel will swell, taking up volume in the small intestine and/or exerting pressure on the wall of the small intestine.
- The polymer hydrogel can optionally be administered in combination with a pH modifying agent, which is an agent which alters the pH of the microenvironment of the polymer hydrogel, thereby modifying its ability to absorb fluids. For example, for polymer hydrogels comprising an anionic polymer, agents which increase the pH of the microenvironment can increase the swellability of the polymer hydrogel. Suitable pH modifying agents for use with the polymer hydrogels of the invention include buffering agents, H2 blockers, proton pump inhibitors, anatacids, proteins, nutritional shakes, and combinations thereof. Suitable buffering agents and antacids include ammonium bicarbonate, sodium bicarbonate, calcium carbonate, calcium hydroxide, aluminium hydroxide, aluminium carbonate, magnesium carbonate, magnesium hydroxide, potassium bicarbonate, potassium carbonate, potassium hydroxide, sodium carbonate, sodium hydroxide and combinations thereof. Suitable H2 blockers include cimetidine, ranitidine, famotidine, nizatidine and combinations thereof. Suitable proton inhibitors include omeprazole, lansoprazole, esorneprazole, pantoprazole, abeprazole, and combinations thereof.
- The present polymer hydrogels can also be used for removing water from the gastrointestinal tract, for example, as a treatment for subjects suffering from kidney disease, including chronic and acute kidney disease, particularly subjects undergoing kidney dialysis. The polymer hydrogels can further be used to modify the fluid content in the gastrointestinal tract of a subject in need thereof, for example, for the treatment of constipation.
- The invention further includes articles of manufacture which comprise the polymer hydrogels of the invention. Such articles of manufacture include articles in which polyacrylic polymer hydrogels are conventionally used, in consumer products, such as for example absorbent products for personal care (i.e., babies' napkins, sanitary towels, etc.) and in products for agriculture (e.g., devices for the controlled release of water and nutrients). The absorption properties of the polymer hydrogels of the invention, which in some embodiments depend on the amount of carboxymethylcellulose employed and which can be improved by the induction of a microporosity in the gel structure, are comparable to those of polyacrylic gels. The polymer hydrogels obtainable by the method of the present invention therefore possess mechanical properties which make them suitable for use in all of the above-mentioned fields. The present polymer hydrogels, however, have advantages over acrylic polymer hydrogels, such as biodegradability, the absence of any toxic by-products during the manufacturing process and the use of fewer and readily available reagents. Such features enable a real employment of the polymer hydrogels of the invention in the biomedical and pharmaceutical fields as well.
- Thus, the polymer hydrogels obtainable by the method of the invention can be used as an absorbent material in products which are capable of absorbing water and/or aqueous solutions and/or which are capable of swelling when brought into contact with water and/or an aqueous solution.
- The polymer hydrogels and superabsorbent polymer hydrogels of the present invention may be used as absorbent materials in the following fields, which are provided by way of nonlimiting example:
- dietary supplements (for example, as the bulking agents in dietary supplements for hypocaloric diets capable of conferring a sensation of lasting satiety being retained into the stomach for a limited period of time, or as water and low molecular weight compounds supplements, such as mineral salts or vitamins, to be included into drinks in a dry or swollen form);
- in agricultural products (for example, in devices for the controlled release of water and/or nutrients and/or phytochemicals, particularly for cultivation in arid, deserted areas and in all cases where it is not possible to carry out frequent irrigation; such products, mixed in a dry form with the soil in the areas surrounding the plant roots, absorb water during irrigation and are capable of retaining it, releasing it slowly in certain cases, together with the nutrients and phytochemicals useful for cultivation);
- in personal hygiene and household absorbent products (such as for example, as the absorbent cores in babies'napkins, sanitary towels and the like);
- in the field of toys and gadgets (such as for example in products which are capable of significantly changing their size once brought into contact with water or an aqueous solution);
- in the biomedical field (for example, in biomedical and/or medical devices such as absorbent dressings for the treatment of highly exudative wounds, such as ulcers and/or bums, or in slow-release polymeric films suitable to slowly release liquids adapted for use in ophthalmology);
- in the body fluid management field, i.e., for controlling the amount of liquids into the organism, for example in products capable of promoting the elimination of fluids from the body, such as, for example, in the case of edema, CHF (chronic heart failure), dialysis.
- The above-mentioned products, containing a polymer hydrogel of the present invention as the absorbent material, also fall within the scope of the invention.
- The polymer hydrogels of the invention can be used in medicine. Such use includes the use of a polymer hydrogel in the preparation of a medicament for the treatment of obesity or any medical disorder or disease in which calorie restriction has a therapeutic, palliative or prophylactic benefit.
- The following examples are provided to further illustrate the invention and are not to be construed as limiting its scope.
- The materials and processes of the present invention will be better understood in connection with the following examples, which are intended as an illustration only and not limiting of the scope of the invention. Various changes and modifications to the disclosed embodiments will be apparent to those skilled in the art and such changes and modifications including, without limitation, those relating to the chemical structures, derivatives, formulations and/or methods of the invention may be made without departing from the scope of the appended claims.
- Any examples not falling within the scope of the claims are provided merely by way of comparative examples or background information.
- CMCNa (MW 700 kDa, DS 0.9, food grade), HEC (MW 250kDa, food grade) were purchased from Eigenmann e Veronelli S.p.A. Milano and citric acid was supplied by Dal Cin S.p.A. Sesto San Giovanni Milano and used as received.
- Polymer hydrogel samples were obtained by reacting, in water, CMCNa and HEC with citric acid as a cross-linking agent according the following procedure. First, a total polymer concentration of 2% by weight of water, using a mixture of CMCNa and HEC, with weight ratio equal to 3/1 was dissolved in distilled water by stirring gently at room temperature until a clear solution was obtained. Poor cross-linking efficiency has been reported if only CMCNa is used, due both to the electrostatic repulsion between polyelectrolyte chains and to the high degree of substitution of hydroxyl groups at C6, the most reactive position [13]. CMCNa dissolution is slow at the concentration adopted; thus, first HEC was added to water till, after 5 min, a clear solution was obtained with a slight increase of viscosity; then, CMCNa was added, and the stirring was kept on till a clear solution was obtained (24h), with a significant increase of viscosity. Finally, CA was added at different concentrations (1.75%, 2.75%, 3.75%, 10% and 20% w/w polymer) in order to obtain samples with various degrees of cross-linking. This final solution was used to mold 10 mm thick samples. All samples were first pre-dried at 30°C for 24 h to remove absorbed water and then kept at 80°C for the cross-linking reaction (24h with intermediate control).
- Moreover, samples containing neat HEC or neat CMCNa samples cross-linked with CA were also prepared following exactly the same experimental conditions used for HEC/CMCNa mixtures.
- All samples were analyzed by FT IR measurements. Anhydride formation was detected by monitoring its characteristic stretching band in the carbonyl region at 1738 cm-1 [14].
- Equilibrium swelling measurements for all the samples were carried out in distilled water using a Sartorius microbalance (10-5 sensitivity). The swelling ratio was measured by weighing samples before and after their immersion in distilled water for about 24 h. The swelling ratio (SR) is defined as following:
- A differential scanning calorimeter (Mettler-Toledo 822e Mettler DSC) was used for thermal analysis. The scanning temperature range and the heating rate were 10-200°C and 5°C/min, respectively.
- The adopted thermal cycle was: (1) heating 10-100°C; (2) isotherm at 100°C for 3 minutes; (3) cooling from 100°C to 10°C; (4) heating from 10°C to 200°C; (5) isotherm at 200°C; (6) cooling until room temperature. An empty pan was used as a reference.
- All FT IR spectra were recorded on a JASCO FT IR 660 plus spectrometer equipped with an attenuated total reflectance (ATR) crystal sampler. Film samples were used directly on a ATR crystal sampler at a resolution of 4 cm-1, by 300 scans, at absorbance range from 4000 cm-1 to 600 cm-1.
- A DSC thermogram of neat citric acid showed a peak at about 60°C, attributable to a water loss process associated with the dehydration leading to an anhydride. A complete degradation, starting at about 160°C, is observed in the second scan.
- DSC analysis of neat CMCNa and HEC powders indicates that some water is still absorbed in the polymers. Above 100°C a possible degradation peak of CMCNa is detected. Both CMCNa and HEC show a thermal stability below 100°C.
- A film of polymer hydrogel obtained using a 3:1 ratio of CMCNa/HEC and 3.75% by weight of polymer of citric acid was analyzed by DSC after drying the sample at 30°C for 24 h and then reduced to powder. A large endothermic peak associated to the evaporation of the water produced by the anhydrification process is evident. A small exothermic peak, attributed to esterification is superimposed on the first one. In the second heating cycle the glass transition (Tg=38°C) of the cross-linked cellulose mixture is observed.
- After this preliminary DSC study, different polymer hydrogel samples were prepared according the following procedures. After mixing reagents in water, the reaction vessel was kept at 30°C for 24 h in dry conditions to remove water. Then temperature was raised above 60°C, according with the results of the first DSC analysis, in order to obtain the citric acid anhydride. Above this limiting temperature citric anhydride is available for the cross-linking reaction with cellulose OH groups. Different reaction conditions were attempted in order to optimize the synthetic procedure, such as temperature and CA concentration as summarized in Table 1. Two different reaction temperatures for the cross-linking process, 80°C and 120°C, were attempted. However, either to prevent degradation risks or to limit the reaction rate a temperature of 80°C was chosen. Moreover, very high concentrations (10% and 20% by weight) of CA were initially used in order to amplify the FT IR signals associated with each chemical reaction step. First neat CMCNa and HEC were cross-linked with CA in order to investigate its reactivity with each of the polymers.
Table 1 Reaction label Initial polymer citric acid concentration
(% w/w polymer)A10 CMCNa 10 A20 CMCNa 20 B10 HEC 10 B20 HEC 20 C10 CMCNa/HEC (3/1) 10 C20 CMCNa/HEC (3/1) 20 - FT IR spectra were recorded of citric acid, of the A10 reaction mixture before heating and of the A10 reaction mixture after 5 h of heating. In the CA spectrum it is possible to observe a strong C=O band centred at 1715 cm-1 due to carboxylic acid. The FT IR spectrum of sample A10 shows a strong absorption band at 1590 cm-1 characteristic of cellulose [16]. After heating, the absorbance band at about 1590cm-1 is still observed and additionally a new band at 1738 cm-1 appears. Anhydrides display two stretching bands in the carbonyl region around 1758 cm-1 and 1828 cm-1. The higher frequency band is the more intense in acyclic anhydrides whereas cyclic anhydrides show the lower frequency C=O stretching band stronger than the stretching band at higher frequency [14]. The new peak observed at 1738 cm-1 can be attributed to the characteristic stretching band of the carbonyl group at lower frequency related to anhydride formation, an intermediate reaction necessary for reaction of CA with cellulose hydroxyl groups. In contrast, the carbonyl peak expected at higher frequency is not detectable probably due to its weak intensity.
- FT IR spectra were recorded of citric acid, B10 reaction mixture before heating and B10 reaction mixture after 6.5 h of heating. The HEC spectrum again shows the band at 1590 cm-1 before and after heating while the absorbance of the carbonyl group at 1738 cm-1 appears only after heating at 80°C as observed for the sample A10.
- Although FT IR analysis is generally considered a qualitative technique, a literature study in literature carried out by Coma and co-workers demonstrated that infrared spectroscopy could be used at first approximation for the determination of the cross-linking rate in cross-linked cellulosic derivatives [9]. Starting from this consideration, the evolution of the different reactions finally leading to cross-linking at 80°C was monitored by recording FT IR spectra at different reaction times.
- The area under the absorbance peak at 1738 cm-1 (A1) representative of the carbonyl group, was compared with the area under the reference absorbance peak at 1592 cm-1 (A2) which is invariant in all spectra. The evolution of the anhydride was evaluated as the ratio of A1/A2 as a function of the reaction time. FTIR spectra of CMCNa polymer when the reaction is performed at 80°C with 20% CA or 10% CA both show a similar trend: the anhydride band, that is absent before heating, reaches a maximum almost immediately after the first hour, successively decreases to a minimum after 3 h, then increasing again reaching a second maximum after 5 h. Finally a slower process reduces the band area to zero after 24 h. It is worth noting that in the spectrum of the 20% CA reaction, the second maximum matches a value (A1/A2 = 0.10) higher than those observed in the 10% CA reaction (A1/A2 = 0.04).
- It is assumed that the peak at around 1738 cm-1 is due to the anhydrification process involving free CA followed by the first condensation of this anhydride with cellulose OH leading to a fast disappearance of the anhydride C=O groups. Then the carboxylate groups now linked to the polymer are able to form again an anhydride leading to an increase of the 1738 cm-1 peak. The second reaction of this anhydride, responsible for the cross-linking, results in a new anhydride group consumption and consequent reduction of the peak at 1738 cm-1. This second reaction is slower since it involves groups linked to large macromolecules and hence is more sterically hindered, as has also been reported for other cellulose cross-linking processes [17]. This possible reaction mechanism is confirmed by the swelling measurements.
- FTIR spectra were also recorded for reactions of HEC polymer when the reaction is performed at 80°C with either 20% CA or 10% CA. In the 10% CA case, the anhydride band intensity increases from 0 to 0.098 when the reaction time increase from 0 h to 6.5 h, but drops to 0 when the reaction time reaches 24 h. The 20% CA reaction follows exactly the same trend providing a maximum value of 0.079 at 5h. Assuming that the cross-linking mechanism is the same as described for CMCNa, the anhydrification and esterification reactions appear superimposed in this case. Therefore, in the FTIR spectra, the HEC polymer shows a single peak. This latter result was in accordance with conclusion of Xie and co-workers [18]. They studied the degree of substitution, as evaluation of cross-linking esterification, on starch thermally reacted with CA at different reaction time and found a maximum after a few hours.
- To explain the data observed in all FTIR spectra recorded after 24 hours, we supposed that in all cases the polymer is unstable when is kept in the oven for 24 hours because of unidentified secondary reactions take place modifying polymer structure that involve also ester functions. Xie and co-workers [18] work guessed that the degree of substitution reached a maximum and then decreased since dissociation of the substituents from starch occurred when the reaction time was longer than 7 h.
- Finally, to complete this study, polymer mixtures of CMCNa and HEC were cross-linked. CMCNa has carboxylic acid functional groups in its structure that increase the volume variation process in solution. A preliminary attempt to follow the reaction pathway failed.
- Probably the reaction systems considered are too complex having many different reaction centers. FT IR spectra of C10 reaction registered before, after 8 h and after 13 h of heating were compared. Reaction sample C20 shows similar spectra. Moreover, it is worth noting that when polymer mixtures are used (C10 and C20) a broad signal appears at about 1715 cm-1, especially when a higher CA concentration is used in the reaction. In fact, with 20% of CA the signal of CA at 1715 cm-1 is very broad and overlapped to the polymer signal at 1590 cm-1 then a clear band is not detectable. However, it should be pointed out a band around 1715cm-1 before heating. The C10 reaction mixture before heating shows a band around 1715 cm-1 covering the absorbance region monitored previously for the other reactions (A10, A20, B10, B20); consequently a clear assignment to the carbonyl group is difficult. However, the other two spectra indicate that this band moves to higher wavenumbers during the cross-linking reaction. In particular after 8 h, the FT IR spectrum shows a broad band in the range of 1711 cm-1 - 1736 cm-1 and after 13h this band appears more clearly as a narrow absorbance band at 1737 cm-1, which is typical of carbonyl groups. Spectra of C20 reaction provide similar results. Although a quantitative analysis of carbonyl groups is not possible when C10 and C20 samples are cross-linked, an evaluation of the carbonyl peak similar to those observed for the reaction of the neat polymers can be assumed.
- The cross-linking kinetics were also monitored studying the swelling behaviour during the reaction progress. Swelling ratio was calculated as a function of the reaction time for: (a) CMCNa with 10% or 20% of CA concentration; (b) HEC with 10% or 20% of CA concentration; (c) the mixture of CMCNa and HEC (3/1) with 10% or 20% CA concentration; (d) the mixture of CMCNa and HEC (3/1) with 1.75%, 2.75% or 3.75% CA concentration.
- The results obtained indicate that the swelling of CMCNa cross-linked with 10% of citric acid is higher than HEC with the same citric acid concentration after 24 h. When 20% of citric acid was added to the celluloses, the shape of the swelling curves are similar for HEC and CMCNa. In this case, as cross-linking proceeds the swelling of HEC based samples decreases faster than CMCNa samples indicating that a higher rate of reaction between CA and HEC. This probably occurs because HEC is less sterically hindered than CMCNa and can react more quickly than CMCNa chains. In addition in each repeating unit, HEC has more OH groups than CMCNa (3 vs 2).
- The maximum swelling of CMCNa/CA sample is observed at the gelation onset, after 3 h, when the second esterification reaction, those leading to cross-linking, begins. Then as the cross-linking process increases the corresponding equilibrium water sorption decreases, confirming the results of FTIR analysis.
- The same reaction mechanism can be assumed for neat HEC cross-linked with CA. However in this case the overall behaviour is slightly different as a consequence of the absence of carboxylic groups bonded to the polymer. The results of swelling experiments must be interpreted taking into account that the CA introduces the high hydrophilic carboxylic groups that are responsible of the formation of a polyelectrolyte network. Therefore the water sorption is significantly increased as carboxylic groups are linked first to the HEC chains and then to the gelled network. This effect cannot be appreciated in CMCNa polymer hydrogels since a large amount of -COOH groups, those linked to the CMCNa chains, is already bonded to the network at the onset of gelation. A similar trend is observed for the mixtures of HEC and CMCNa.
- Polymer hydrogels of practical use presenting a high degree of swelling were obtained with a reduced concentration of citric acid (1.75%, 2.75%, 3.75% by weight of polymer). With a citric acid concentration of 3.75% the swelling ratio can reach 900. This polymer hydrogel, after swelling, is characterized by adequate stiffness and it is able to keep the same shape of the synthesis vat. Polymer hydrogels formerly synthesized [13] using divinyl sulfone, a toxic reagent, as cross-linking agents and the same ratio between CMCNa and HEC were characterized by a maximum swelling ratio of 200. In this case a higher swelling ratio is obtained using an environmentally friendly cross-linking agent. At concentrations lower than 1.75% CA, a weak cross-linking associated with insufficient mechanical property is observed.
- This work shows for the first time that CA can be successfully used as cross-linking agent of CMCNa/HEC mixtures. As shown in
Figure 1 , an esterification mechanism based on an anhydride intermediate formation is proposed to explain the reaction of cellulose polymers with CA. - The cross-linking reaction for CMCNa/HEC system was observed either by DSC or by FTIR analysis. The evolution of the different cross-linking reactions was monitored by means of FT IR spectra collected at different reaction times using an excess of citric acid. The swelling ratio, monitored at different reaction times, confirmed the reaction path figured out from FTIR analysis. An optimal degree of swelling (900) for practical applications was achieved using low CA concentrations. The polymer hydrogel obtained through the method described in this Example 1 has the great advantage to reduce primary and production costs and avoid any toxic intermediate during its synthetic process.
- All the materials employed were provided by Aldrich Italia and were used without any further modification. The devices used in the characterisation, in addition to the standard laboratory glassware, cupboards and counters for standard synthesis, were a scanning electron microscope (SEM) JEOL JSM-6500F, a precision 10'5g Sartorius scale, an Isco mixer and an ARES rheometer.
- The polymer hydrogels were prepared by cross-linking an aqueous solution of carboxymethylcellulose sodium salt (CMCNa) and hydroxyethylcellulose (HEC), using citric acid (CA) as the cross-linking agent and sorbitol as the molecular spacer. The composition of a gel is given by the nominal amount of the reagents in the starting solution. The parameters used to define said composition are the following:
- The laboratory tests demonstrated that a polymer concentration lower than 2% and a CA concentration lower than 1% either do not achieve cross-linking of the gel or led to the synthesis of a gel having very poor mechanical properties. On the other hand, CA concentrations higher than about 5% significantly increase the cross-linking degree and polymer stabilization, but excessively reduce the absorption properties of the superabsorbent gel.
- Since CMCNa is the ionic polymer species, it is possible to achieve the desired absorption properties adjusting the weight ratio of carboxymethylcellulose sodium salt (CMCNa) to hydroxyethylcellulose (HEC). A CMCNa/HEC weight ratio of between 0/1 and 5/1, preferably between 1/1 and 3/1, was observed to enable the synthesis of a polymer hydrogel having optimum absorption properties.
- Examples relating to the synthesis of different polymer hydrogels according to the invention, differing from one another in the weight percent (wt%) of citric acid and in the composition of the polymeric precursor, are provided below.
- Preparation of polymer hydrogel A: in a beaker containing distilled water, sorbitol at a concentration of 4% by weight referred to the weight of distilled water was added and mixed until complete solubilisation, which occured within a few minutes. The CMCNa and HEC polymers are added at a total concentration of 2% by weight referred to the weight of distilled water, with a CMCNa/HEC weight ratio of 3/1. Mixing proceeded until solubilisation of the whole quantity of polymer is achieved and the solution became clear. At this stage, citric acid at a concentration of 1% by weight referred to the weight of the precursor was added to the solution, whose viscosity had greatly increased. The solution thereby obtained was poured into a vessel and dried at 48°C for 48 hours. During this process, the macromolecules are stabilised into a polymeric network which is the backbone of the polymer hydrogel. At the end of the cross-linking process, the polymer hydrogel was washed with distilled water for 24 hours at room temperature. During this phase, the polymer hydrogel swelled up thereby eliminating the impurities. In order to obtain the maximum swelling degree and elimination of all of the impurities, at least 3 rinses with distilled water were performed during the 24 hours washing step. At the end of this washing step, the polymer hydrogel was dried by phase inversion in acetone as the nonsolvent, until a glassy white precipitate is obtained. The precipitate is then placed into an oven at 45°C for about 3 hours, to remove any residual trace of acetone.
- Preparation of polymer hydrogel B: Polymer hydrogel B was prepared as polymer hydrogel A, with the only exception that the polymer is made only of CMCNa, and that the CMCNa concentration is 2% by weight referred to the weight of distilled water.
- Preparation of polymer hydrogel C: Polymer hydrogel C was prepared as polymer hydrogel B, with the only exception that the citric acid concentration is 2% by weight referred to the weight of CMCNa.
- Preparation of polymer hydrogel D: Polymer hydrogel D was prepared as polymer hydrogel B, with the only exception that the citric acid concentration is 0.5% by weight referred to the weight of CMCNa.
- In order to test the absorption properties of the polymer hydrogels prepared as described above, they were subjected to absorption measurements in distilled water. The absorption measurements essentially consist of placing the dry sample, obtained from the drying step, in distilled water, so that it swells up until an equilibrium condition is reached.
- The absorption properties of the gel are assessed based on its swelling ratio (SR), defined according to the formula illustrated above. In order to minimise the influence of experimental errors, each test was performed on three samples from each gel, and then the mean value of the results of the three measurements was taken as the effective value.
- Three dry samples were taken from each of the test gels, each having different weights and sizes. After recording the weights, the samples were swollen in abundant quantities of distilled water at room temperature. Upon reaching equilibrium after 24 hours, the samples were weighed once more in order to determine the swelling ratio.
- Table 2 below reports some of the results obtained, in terms of the swelling ratio, varying the concentrations of the reagents and the cross-linking times (6 hours, 13 hours, 18 hours, 24 hours).
Table 2 Sample CMCNa HEC CA sorbitol cross-linking time/swelling ratio - 75% 25% - - 6 hours 13 hours 18 hours 24 hours g16 2% 1% 4% nr 50 30 20 g17 4% 1% 4% nr 25 10 5 nr = not cross-linked - It is pointed out that the increase in the polymer concentration exerts a negative effect on the swelling properties of the final product and it is also pointed out that the cross-linking time exerts a significant effect of the absorbing properties.
- Thus, further experiments were carried out maintaining the polymer concentration fixed at 2% and varying the citric acid concentration. The results are reported in Table 3.
Table 3 Sample CMCN a HEC CA sorbitol cross-linking time/swelling ratio - 75% 25% - - 6 hours 13 hours 18 hours 24 hours g21 2% 2% 4% 40 25 20 10 g22 2% 1% 4% nr 50 30 20 g23 2% 0.5 % 4% nr Nr 50 30 nr = not cross-linked - Table 3 shows that the sample having the best swelling ratio is the sample designated as g22, which is characterised by a citric acid (CA) concentration of 1%.
- Thus, further experiments were performed removing completely HEC from the solution. This should render the polymer hydrogel more hydrophilic thereby leading to an increase of the swelling ratio. Table 4 shows some of the results obtained.
Table 4 Sample CMCN a HEC CA sorbitol cross-linking time/swelling ratio 100% 0% - - 6 hours 13 hours 18 hours 24 hours g30 2% 2% 4% nr 85 55 30 g31 2% 1% 4% nr 100 75 40 g32 2% 0,5% 4% nr Nr 70 50 nr = not cross-linked - The highest swelling ratio is associated with a cross-linking time of 13 hours and a citric acid concentration of 1%. It is also to be noticed that higher citric acid concentrations together with shorter cross-linking times lead to equally satisfactory swelling ratios, although the reaction is very fast and less easy to control.
- Finally, the possibility of increasing the swelling ratio by creating porosity into the material which could promote the absorbing properties, was evaluated. For that purpose, the sample g31, subjected to cross-linking for 12 hours, was swelled into distilled water for 24 hours and then dried by phase inversion in acetone. With this technique, a swelling ratio of 200 was obtained.
- This example describes an evaluation of the superabsorbent polymer hydrogel denoted polymer hydrogel B in Example 2 in in vitro swelling and collapsing experiments in various media at 37°C.
- 100 mg of the dried polymer hydrogel was immersed in either simulated gastric fluid ("SGF") or a mixture of SGF and water and allowed to swell until an equilibrium condition was reached. SGF was prepared according to USP Test Solutions procedures. The swelling ratio in each fluid was determined at various time points. The results are set forth in Tables 5 and 6.
Table 5. Swelling of dry polymer hydrogel B in 100 % SGF at 37°C. The weights were recorded at 15, 30, 60 and 90 min. Swelling Time, min Swelling Ratio, g/g 15 15.4 30 15.6 60 16.2 90 15.1 Table 6. Swelling of Dry Polymer hydrogel B in a mixture of SGF and Water (1:8) at 37°C. The weights were recorded at 15, 30, 60 and 90 min. Sweling Time, min Swelling Ratio, g/g 15 78.8 30 84.6 60 88.6 90 79.3 - To simulate the effect of digestion on a hydrated polymer hydrogel, to the swollen polymer hydrogel from above (Table 6, SGF/water) after 60 minutes, 100% SGF was slowly added to collapse the gel particles. Swelling ratio was monitored as a function of cumulative volume of added SGF. The results are set forth in Table 7.
Table 7 SGF added (mL) Swelling Ratio (g/g) 0 88.6 8 23.1 30 22.6 50 23.1 75 17.1 - Experiments were conducted by monitoring the swelling ratio through a full cycle of swelling in 1:8 SGF/water, collapsing in SGF, and re-swelling (then degradation) in simulated intestinal fluid (SIF), all at 37°C. Experiments performed and results are provided in Table 8, for the re-swelling/degradation kinetics. pH values are given when available.
Table 8. Kinetics of swelling in SGF/water, collapsing in SGF, and re-swelling in SIF Expt. # 60-min Swell in SGF/water Collapse in 70-mL SGF Re-swelling / Degradation in SIF Swell Ratio Swell Ratio 30 min 45 min 90 min 120 min 1 95.5 pH 4.82 20.7 pH 1.76 71.2 87.3 2 95.3 19.5 pH 1.75 72.6 80.5 - This polymer hydrogel swells in simulated gastric fluids (pH 1.5) approximately 15 fold, and in a simulated gastric fluids/water mixture (pH 3) approximately 85 fold. This indicates that the polymer hydrogel has a pH/swelling correlation where at pH below 3 (pKa of CMC is ~3.1) there will be limited swelling of the polymer hydrogel due to absence of the Donnan effect. The polymer can also swell in the increased pH of simulated intestinal fluid.
- A series of experiments was conducted to assess the effect of polymer hydrogel B in laboratory animals. One objective of these studies was to determine the effect of polymer hydrogel B on food intake in rats. The study was conducted in male Sprague Dawley rats, by acute administration of pre-swollen polymer hydrogel B by oral gavage
- A total of 22 male Sprague-Dawley rats were randomized into two weight-matched groups prior to polymer hydrogel or vehicle administration (the polymer hydrogel B was pre-swollen in water, 100 mg in 10 mL water). Food and water intake (digital balance) as well as locomotor activity (consecutive beam brakes) were monitored online every 5 minutes for 40 hours post dosing. Food and water intake data were collected using MaNi FeedWin, an online computerized feeding system using digital weighing cells. Two types of baseline food intake (digital balance) and lick counts were monitored. All data was entered into Excel spreadsheets and subsequently subjected to relevant statistical analyses Results are presented as mean ± SEM unless otherwise stated. Statistical evaluation of the data is carried out using one-way or two-way analysis of variance (ANOVA).
-
Figure 2 , a graph of cumulative food intake as a function of time, represents a typical study result. There was no difference between the groups at base line. Gavage of 8 mL of polymer hydrogel B induced satiety in the rats that led to a significant decrease in food intake. As shown in the yellow line, this polymer hydrogel induced a marked decrease in food intake that persisted over 2 hours. These data suggest that polymer hydrogel B can induce satiety in animals and leads to a decrease in food intake. -
- [1] Anbergen U, Opperman W, Polymer, 31, 1854 (1990)
- [2] Esposito F et al., J Appl Polym Sci, 60, 2403 (1996)
- [3]
Denn WL, Ferguson GN, US 3,589,364, 1971 - [4]
Sachetto JP et al., ES 484964, 1978 - [5] Choi YS et al., Biomaterials, 20, 409 (1999)
- [6] International patent application
WO 2006/070337 - [7] Glusker JP. Acc. Chem. Res. 1980;13:345-352
- [8] Wang CC et al., Applied Catalysis A: General 2005;293:171-179
- [9] Coma V et al., Carbohydrate Polymers 2003;51:265-271
- [10] Xie XS et al., Food Research International 2006;39:332-341
- [11] Yang CQ et al., J. Appl. Polym. Sci. 1998;70:2711-2718
- [12] Flory P.J., Principles of Polymer Chemistry, Ithaca, NY: Cornell University Press, 1953
- [13] Sannino A. et al., Polymer 2005; 46:4676
- [14] Silverstein R.M., et al. Spectrometric Identification of Organic Compounds, Wiley, 1991, pp 120-130.
- [15] Peppas NA, Polymer hydrogels in Medicine and Pharmacy; CRC Press, Boca Raton, Florida, 1987, p.29
- [16] Chen CC and Wang CC, J. Sol-Gel Sci. Technol. 2006, 40: 31.
- [17] Xie XS and Liu Q, Starch 2004, 56:364
- [18] Khutoyanskaya OV et al., Macromol. Chem. Phys. 2005, 206:1497
Claims (19)
- A method for preparing a polymer hydrogel, comprising the steps of:(a) preparing an aqueous solution comprising one or more hydrophilic polymers, a polycarboxylic acid selected from C4-C12-dicarboxylic acids, tricarboxylic acids and tetracarboxylic acids and a polyhydroxylated compound selected from plant glycerol, monosaccharides, disaccharides and sugar alcohols; and(b) heating the aqueous solution to remove water and cross-link the one or more hydrophilic polymers, thereby forming a polymer hydrogel.
- The method of claim 1 wherein the one or more hydrophilic polymers are selected from the group consisting of polyallyl alcohol, polyvinyl alcohol and polysaccharides, preferably selected from the group consisting of substituted celluloses, substituted dextrans, substituted starches, glycosaminoglycans and polyuronic acids, more preferably selected from the group consisting of C1-C6-alkylcelluloses, hydroxy-C1-C6-alkylcelluloses,hydroxy-C1-C6-alkyl-C1-C6-alkylcelluloses, methylcellulose, ethylcellulose, n-propylcellulose, hydroxyethylcellulose, hydroxy-n-propylcellulose, hydroxy-n-butylcellulose, hydroxypropylmethylcellulose, ethylhydroxyethylcellulose, carboxymethylcellulose, carboxymethylstarch, dextran sulfate, dextran phosphate, diethylaminodextran, heparin, hyaluronan, chondroitin, chondroitin sulfate, heparan sulfate, polyglucuronic acid, polymanuronic acid, polygalacturonic acid and polyarabinic acid.
- The method of any preceding claim wherein the hydrophilic polymers comprise at least two hydrophilic polymers, preferably an ionic polymer and a nonionic polymer.
- The method of claim 3 wherein the ionic polymer is carboxymethylcellulose and the nonionic polymer is hydroxyethylcellulose.
- The method of any preceding claim wherein the polycarboxylic acid is selected from the group consisting of citric acid, malonic acid, malic acid, maleic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, phthalic acid, o-phthalic acid, isophthalic acid, m-phthalic acid, terephthalic acid, , isocitric acid, aconitic acid, propane-1,2,3-tricarboxylic acid, pyromellitic acid, 2,3,3',4'-biphenyltetracarboxylic acid, 3,3',4,4'-tetracarboxydiphenylether, 2,3',3,4'-tetracarboxydiphenylether, 3,3',4,4'-benzophenonetetracarboxylic acid, 2,3,6,7-tetracarboxynaphthalene, 1,4,5,7-tetracarboxynaphthalene, 1,4,5,6-tetracarboxynaphthalene, 3,3',4,4'-tetracarboxydiphenylmethane, 2,2-bis(3,4-dicarboxyphenyl)propane, butanetetracarboxylic acid and cyclopentanetetracarboxylic acid.
- The method of claim 5 wherein the hydrophilic polymer is carboxymethylcellulose, preferably carboxymethylcellulose sodium salt, and the polycarboxylic acid is citric acid.
- The method of any preceding claim wherein the polyhydroxylated compound is selected from the group consisting of sucrose, sorbitol, plant glycerol, mannitol, trehalose, lactose, maltose, erythritol, xylitol, lactitol, maltitol, arabitol, glycerol, isomalt and cellobiose.
- The method of any preceding claim, further comprising the step of:(c) washing the polymer hydrogel with water, a polar organic solvent or a combination thereof, thereby producing a washed polymer hydrogel; and(d) drying the washed polymer hydrogel, preferably by;(i) immersing the washed polymer hydrogel in a cellulose nonsolvent; and/or(ii) drying the washed polymer hydrogel in an oven.
- The method of claim 5 wherein said polycarboxylic acid is citric acid.
- The method of any preceding claim, wherein step (b) comprises:(i) heating the solution to produce a dry residue; and(ii) heating the dry residue.
- A polymer hydrogel produced by the method of any one of claims 1 to 10.
- The polymer hydrogel of claim 11, wherein the hydrophilic polymer is carboxymethylcellulose, the polycarboxylic acid is citric acid and the polyhydroxylated compound is sorbitol.
- A method for producing a polymer hydrogel, comprising the steps of:(a) preparing an aqueous solution of carboxymethylcellulose, preferably carboxymethylcellulose sodium salt, and citric acid:(b) heating the aqueous solution to remove water and cross-link the carboxymethylcellulose, thereby forming a polymer hydrogel;(c) washing the polymer hydrogel with water, a polar organic solvent or a combination thereof, thereby producing a washed polymer hydrogel; and(d) drying the washed polymer hydrogel by immersing the washed polymer hydrogel in a cellulose nonsolvent, thereby producing the polymer hydrogel.
- The method of claim 9 or claim 13 wherein the concentration of carboxymethylcellulose in the aqueous solution is at least 2% by weight compared to water and the concentration of citric acid is from 1 to 5% by weight compared to carboxymethylcellulose.
- A polymer hydrogel produced by the method of claim 13 or claim 14.
- The polymer hydrogel of claim 12, comprising sorbitol.
- The polymer hydrogel of any of claim 11, 12, 15 or 16 having a swelling ratio of at least 10, 50 or 100.
- An article of manufacture comprising a polymer hydrogel of any of claims 11, 12, or 14 to 16.
- The article of manufacture of claim 18, wherein said article of manufacture is selected from the group consisting of devices and pharmaceuticals for eliminating water or aqueous solutions from a body, devices for the controlled release of water, nutrients or phytopharmaceuticals in agriculture, absorbent products for personal and household hygiene, toys and devices adapted to altering their size when brought into contact with water or aqueous solutions, biomedical devices, and polymeric films capable of slowly releasing liquids in ophthalmology.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20120176918 EP2532685B1 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and use thereof |
PL12158633T PL2463308T3 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and medical use thereof |
DK12158633.3T DK2463308T3 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and their medical use |
EP20120176382 EP2535359A1 (en) | 2007-08-10 | 2008-08-08 | Controlled release agricultural products |
DK12176918T DK2532685T3 (en) | 2007-08-10 | 2008-08-08 | The polymer hydrogels and the use thereof |
PL12176918T PL2532685T3 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and use thereof |
EP20120158633 EP2463308B1 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and medical use thereof |
EP20120176381 EP2514444A1 (en) | 2007-08-10 | 2008-08-08 | Absorbent product for personal care |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IT2007/000584 WO2009022358A1 (en) | 2007-08-10 | 2007-08-10 | Superabsorbent polymer hydro gels and a method of preparing thereof |
PCT/EP2008/006582 WO2009021701A2 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and methods of preparation thereof |
Related Child Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20120176382 Division-Into EP2535359A1 (en) | 2007-08-10 | 2008-08-08 | Controlled release agricultural products |
EP20120158633 Division EP2463308B1 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and medical use thereof |
EP20120158633 Division-Into EP2463308B1 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and medical use thereof |
EP20120176381 Division-Into EP2514444A1 (en) | 2007-08-10 | 2008-08-08 | Absorbent product for personal care |
EP20120176918 Division-Into EP2532685B1 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and use thereof |
EP20120176918 Division EP2532685B1 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2178922A2 EP2178922A2 (en) | 2010-04-28 |
EP2178922B1 true EP2178922B1 (en) | 2015-10-07 |
Family
ID=39312966
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20120176382 Withdrawn EP2535359A1 (en) | 2007-08-10 | 2008-08-08 | Controlled release agricultural products |
EP20120176918 Active EP2532685B1 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and use thereof |
EP08785471.7A Active EP2178922B1 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and methods of preparation thereof |
EP20120176381 Withdrawn EP2514444A1 (en) | 2007-08-10 | 2008-08-08 | Absorbent product for personal care |
EP20120158633 Active EP2463308B1 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and medical use thereof |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20120176382 Withdrawn EP2535359A1 (en) | 2007-08-10 | 2008-08-08 | Controlled release agricultural products |
EP20120176918 Active EP2532685B1 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and use thereof |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20120176381 Withdrawn EP2514444A1 (en) | 2007-08-10 | 2008-08-08 | Absorbent product for personal care |
EP20120158633 Active EP2463308B1 (en) | 2007-08-10 | 2008-08-08 | Polymer hydrogels and medical use thereof |
Country Status (18)
Country | Link |
---|---|
US (5) | US8658147B2 (en) |
EP (5) | EP2535359A1 (en) |
JP (5) | JP5485151B2 (en) |
CN (2) | CN101796075B (en) |
AU (1) | AU2008286354B2 (en) |
CA (1) | CA2695974C (en) |
CY (2) | CY1115978T1 (en) |
DK (2) | DK2532685T3 (en) |
ES (3) | ES2526905T3 (en) |
HK (1) | HK1172633A1 (en) |
HR (1) | HRP20150121T1 (en) |
HU (2) | HUE024121T2 (en) |
MX (1) | MX2010001629A (en) |
PL (2) | PL2463308T3 (en) |
PT (2) | PT2463308E (en) |
RU (2) | RU2493170C2 (en) |
SI (2) | SI2463308T1 (en) |
WO (2) | WO2009022358A1 (en) |
Families Citing this family (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2010001629A (en) * | 2007-08-10 | 2010-08-09 | Alessandro Sannino | Polymer hydrogels and methods of preparation thereof. |
AU2009316622B2 (en) | 2008-11-18 | 2014-09-04 | Gelesis Llc | Methods and compositions for weight management and for improving glycemic control |
IT1393778B1 (en) | 2009-04-06 | 2012-05-08 | Sannino | PROCEDURE FOR WASTE TREATMENT. |
ES2671907T3 (en) * | 2010-01-13 | 2018-06-11 | Georg Bischof | Composition for the generation of a temporary intestinal occlusion |
GB201000879D0 (en) * | 2010-01-20 | 2010-03-10 | Univ Reading The | Improved hydrogel synthesis |
CN101983974B (en) * | 2010-10-08 | 2014-07-16 | 青岛聚大洋海藻工业有限公司 | Extracting and processing technology of food additive G-type alginate |
RU2455007C1 (en) * | 2010-11-01 | 2012-07-10 | Учреждение Белорусского государственного университета "Научно-исследовательский институт физико-химических проблем" | Method for producing gel-forming dextrane phosphates |
IT1404015B1 (en) * | 2011-02-04 | 2013-11-08 | Hsd Holding Smart Device S R L | USE OF A DESTRANO POLYMER RETICULATED AS A FILTER AGAINST INHALATION OF HEALTH HARMFUL SUBSTANCES |
JP6135896B2 (en) * | 2011-03-25 | 2017-05-31 | Jsr株式会社 | Polymer gel and method for producing the same |
WO2012148953A1 (en) * | 2011-04-25 | 2012-11-01 | Stc.Unm | Solid compositions for pharmaceutical use |
US9760009B2 (en) * | 2011-05-13 | 2017-09-12 | Clarkson University | Cross-linked polymer based hydrogel material compositions, methods and applications |
CN103917092B (en) * | 2011-06-07 | 2018-04-24 | 珍尔希斯股份有限公司 | The method for producing hydrogel |
JP2013129612A (en) * | 2011-12-20 | 2013-07-04 | Kao Corp | Medicine for sustaining feeling of fullness |
KR101212504B1 (en) * | 2012-06-21 | 2012-12-24 | 염다원 | Antimicrobial hydrogel comprising coptis chinesis |
US9145340B2 (en) | 2012-08-13 | 2015-09-29 | Verdesian Life Sciences, Llc | Method of reducing atmospheric ammonia in livestock and poultry containment facilities |
CN103724633A (en) * | 2012-10-15 | 2014-04-16 | 中国科学院兰州化学物理研究所 | Granular hydrogel |
US9961922B2 (en) | 2012-10-15 | 2018-05-08 | Verdesian Life Sciences, Llc | Animal feed and/or water amendments for lowering ammonia concentrations in animal excrement |
RU2519927C1 (en) * | 2013-01-18 | 2014-06-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Южно-Российский государственный университет экономики и сервиса" (ФГБОУ ВПО "ЮРГУЭС") | Heat-removing clothing design |
ITRM20130088A1 (en) * | 2013-02-14 | 2014-08-15 | Jaber Innovation S R L | SUPER-ABSORBENT BIODEGRADABLE HYDROGELS |
WO2014168915A1 (en) * | 2013-04-12 | 2014-10-16 | Dow Global Technologies Llc | Process for preparing an aqueous solution of a methylcellulose |
US10512957B2 (en) | 2013-08-02 | 2019-12-24 | Regenesis Bioremediation Products | Colloidal agents for aquifer and metals remediation |
US9770743B2 (en) * | 2013-08-02 | 2017-09-26 | Regenesis Bioremediation Products | Colloidal agents for aquifer remediation |
US11254620B2 (en) | 2013-08-05 | 2022-02-22 | Verdesian Life Sciences U.S., Llc | Micronutrient-enhanced polymeric seed coatings |
TW201522390A (en) | 2013-08-27 | 2015-06-16 | 特級肥料產品公司 | Polyanionic polymers |
CA2923561C (en) | 2013-09-05 | 2022-05-03 | Verdesian Life Sciences, Llc | Polymer-boric acid compositions |
WO2016056019A1 (en) | 2013-12-20 | 2016-04-14 | Reliance Industries Limited | Water absorbent polymers and a process for their preparation |
WO2015097033A1 (en) * | 2013-12-23 | 2015-07-02 | Basf Se | Polysaccharide hydrogels |
CN103788217B (en) * | 2013-12-26 | 2016-05-11 | 昆明理工大学 | A kind of cellulose gel glue material, Preparation method and use |
WO2015157261A1 (en) * | 2014-04-10 | 2015-10-15 | Basf Se | Oral care compositions |
CN103962111B (en) * | 2014-05-08 | 2016-02-17 | 闽江学院 | Cationic water gel rubber material |
CA2945823C (en) | 2014-05-21 | 2022-04-26 | Verdesian Life Sciences, Llc | Polymer soil treatment compositions including humic acids |
CA2946202C (en) | 2014-05-22 | 2022-06-21 | Verdesian Life Sciences, Llc | Polymeric compositions |
CN115381850A (en) | 2014-06-20 | 2022-11-25 | 吉莱斯公司 | Method for treating overweight or obesity |
EP3250612B1 (en) | 2015-01-29 | 2020-12-02 | Gelesis LLC | Method for producing hydrogels coupling high elastic modulus and absorbance |
BR112017024451A2 (en) | 2015-05-18 | 2018-07-24 | Zymtronix Llc | solid and liquid antimicrobial compositions, agricultural product, liquid pesticide product, seed coating, improved seed, animal bed, wound dressing, tissue, methods of improving the yield of a plant product and an animal product, method of reducing septicemia , method of production of antimicrobial composition, and method for reducing or eliminating growth of microbial pests |
WO2016201230A1 (en) | 2015-06-10 | 2016-12-15 | Rhodia Operations | Phosphonated polysaccharides and gels and process for making same |
JP2018519838A (en) | 2015-07-15 | 2018-07-26 | ザイムトロニクス エルエルシーZymtronix, Llc | Automated bionanocatalyst production |
EP3144340A1 (en) | 2015-09-17 | 2017-03-22 | Solvay Acetow GmbH | Polymer gels, method of preparation and uses thereof |
WO2017061166A1 (en) * | 2015-10-05 | 2017-04-13 | ユニ・チャーム株式会社 | Biodegradable water absorbent and method for producing same |
JP6407204B2 (en) * | 2015-10-05 | 2018-10-17 | ユニ・チャーム株式会社 | Biodegradable water-absorbing agent and production method thereof |
JP2019505535A (en) | 2016-02-05 | 2019-02-28 | エントレガ,インコーポレイテッド | Oral formulation containing desiccant for delivery of active agent |
CA3020916C (en) * | 2016-04-16 | 2024-04-30 | Zymtronix Catalytic Systems, Inc. | Magnetic macroporous polymeric hybrid scaffolds for immobilizing bionanocatalysts |
RU2745992C2 (en) * | 2016-04-25 | 2021-04-05 | Джелесис ЭлЭлСи | Obstipation treatment method |
CN105860107B (en) * | 2016-04-26 | 2018-02-09 | 中南大学 | A kind of hydrogen peroxide response and the preparation method of the aquagel with electro-chemical activity |
US11596605B2 (en) | 2016-08-01 | 2023-03-07 | The Brigham And Women's Hospital, Inc. | Particles for delivery of proteins and peptides |
RU175482U1 (en) * | 2016-08-04 | 2017-12-06 | Федеральное государственное бюджетное учреждение науки Институт высокомолекулярных соединений Российской академии наук | EXECUTIVE DEVICE |
CA3031802A1 (en) | 2016-08-13 | 2018-02-22 | Zymtronix Catalytic Systems, Inc. | Magnetically immobilized biocidal enzymes and biocidal chemicals |
SE1651136A1 (en) * | 2016-08-24 | 2018-02-25 | Organoclick Ab | Bio-based pec compositions as binders for fiber based materials, textiles, woven and nonwoven materials |
MX2016012389A (en) * | 2016-09-23 | 2018-03-22 | O Sullivan Barrera Michael Jr | A cross-linked structure for tissue regeneration and engineering and the method for synthesising the same. |
EP3538066B1 (en) * | 2016-11-11 | 2021-12-29 | Anteis SA | Hyaluronic acid dermal fillers crosslinked with citric acid, method for making same and uses thereof |
US10603070B2 (en) | 2016-12-05 | 2020-03-31 | Daniel E. Walzman | Alternative use for hydrogel intrasaccular occlusion device with a spring for structural support |
US10448970B2 (en) | 2016-12-05 | 2019-10-22 | Daniel E. Walzman | Alternative use for hydrogel intrasaccular occlusion device with telescoping central support element |
CA3055985A1 (en) | 2017-03-22 | 2018-09-27 | Genentech, Inc. | Hydrogel cross-linked hyaluronic acid prodrug compositions and methods |
CN110740759B (en) | 2017-04-05 | 2022-05-06 | 吉莱斯公司 | Improved superabsorbent materials and methods for making the same |
KR20200003827A (en) * | 2017-04-14 | 2020-01-10 | 젤레시스 엘엘씨 | Compositions and Methods for Treating or Preventing Intestinal Permeability-Related Disorders |
FR3068039B1 (en) | 2017-06-22 | 2020-07-10 | Jellynov | SELF-FOAMING COMPOSITION IN ACID MEDIUM AND PREPARATION METHOD |
GB201711644D0 (en) | 2017-07-19 | 2017-08-30 | Satie8 Ltd | Polymer Compositions |
RU2020105297A (en) * | 2017-07-28 | 2021-08-05 | Кимберли-Кларк Ворлдвайд, Инк. | NANOPOROUS SUPERABORATIVE PARTICLES |
WO2019023066A1 (en) | 2017-07-28 | 2019-01-31 | Kimberly-Clark Worldwide, Inc. | Absorbent article having a reduced humidity level |
WO2019059425A1 (en) * | 2017-09-19 | 2019-03-28 | 주식회사 엘지생활건강 | Hyaluronic acid filler using microneedle patch |
IT201700105979A1 (en) * | 2017-09-21 | 2019-03-21 | Giacomo Guerrini | Biodegradable polymer-composite clay - Biodegradable polymer-clay composite |
CN108003391A (en) * | 2017-12-01 | 2018-05-08 | 武汉理工大学 | A kind of full polysaccharide derivates base superabsorbent hydrogel and its preparation method and application |
DE112017008257A5 (en) | 2017-12-07 | 2020-09-24 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | PROCESS FOR CROSSLINKING POLYMERS WITH NUCLEOPHILIC FUNCTIONALITIES, CROSSLINKED POLYMERS AND USES THEREOF |
CN108354166A (en) * | 2018-02-06 | 2018-08-03 | 吉林农业大学 | A kind of high dietary-fiber cornstarch gel and preparation method thereof |
AU2019225742A1 (en) * | 2018-02-20 | 2020-09-17 | Advanced Aesthetic Technologies, Inc. | High concentration hydrogels and related methods |
US11596924B2 (en) | 2018-06-27 | 2023-03-07 | Kimberly-Clark Worldwide, Inc. | Nanoporous superabsorbent particles |
MX2020012824A (en) * | 2018-06-27 | 2021-02-16 | Kimberly Clark Co | Absorbent article containing nanoporous superabsorbent particles. |
CN110732037B (en) | 2018-07-20 | 2023-05-26 | 广州倍绣生物技术有限公司 | Hemostatic paste and preparation method thereof |
CN110064344B (en) * | 2018-09-07 | 2023-03-28 | 中北大学 | Folic acid supramolecular organogel with high thermal stability |
FR3089224B1 (en) | 2018-12-04 | 2020-12-11 | Jellynov | Self-foaming composition in an acid medium and method of preparation |
AU2020217732A1 (en) * | 2019-02-06 | 2021-09-30 | TearClear Corp. | Systems and methods for preservative removal from ophthalmic formulations comprising complexing agents |
CN109675096B (en) * | 2019-02-21 | 2021-03-12 | 武汉纺织大学 | Preparation method of chitosan fiber hydrogel dressing |
CN111187429B (en) * | 2019-06-18 | 2020-08-14 | 吾奇生物医疗科技(镇江)有限公司 | Double-crosslinking collagen hydrogel material, and preparation method and application thereof |
CN110496135B (en) * | 2019-09-27 | 2022-02-01 | 南京易亨制药有限公司 | Composition for losing weight |
JP2022550457A (en) * | 2019-10-01 | 2022-12-01 | ブリリアン・ファーマ・インコーポレイテッド | Methods of treating or preventing obesity and weight management |
KR20220144359A (en) | 2019-12-19 | 2022-10-26 | 티어클리어 코포레이션 | Removal of preservatives from eye drops |
CN111218013B (en) * | 2020-01-22 | 2022-08-23 | 上海应用技术大学 | Preparation method and application of crosslinked polymer |
RU2743941C1 (en) * | 2020-07-29 | 2021-03-01 | Федеральное государственное бюджетное учреждение науки Институт химии Дальневосточного отделения Российской академии наук (ИХ ДВО РАН) | Method for producing biopolymeric hydrogel |
CN112341672B (en) * | 2020-10-22 | 2022-03-04 | 爱美客技术发展股份有限公司 | Modified cross-linked carboxymethyl cellulose gel and preparation method thereof |
CN112262984B (en) * | 2020-11-03 | 2021-12-14 | 吴良平 | Hydrogel for assisting in diet control and preparation method and application thereof |
CN112263563A (en) * | 2020-11-03 | 2021-01-26 | 吴良平 | Hydrogel with bowel relaxing function and preparation method and application thereof |
CN112876307B (en) * | 2021-01-21 | 2022-09-20 | 西北师范大学 | Degradable super absorbent resin with nitrogen fertilizer slow-release effect and preparation method thereof |
CN112915974A (en) * | 2021-02-05 | 2021-06-08 | 青岛科技大学 | Malic acid-chitosan nanopore hydrogel microspheres and preparation method and application thereof |
RU2766223C1 (en) * | 2021-03-10 | 2022-02-10 | Федеральное государственное бюджетное учреждение науки Институт химии Дальневосточного отделения Российской академии наук (ИХ ДВО РАН) | Method for obtaining biopolymer films |
US20240189433A1 (en) * | 2021-03-23 | 2024-06-13 | Junion Labs Pte. Ltd. | Superabsorbent hydrogels |
WO2023038575A2 (en) * | 2021-09-09 | 2023-03-16 | Junion Labs Pte. Ltd. | Superabsorbent hydrogels with lipase inhibitor |
CN113854567A (en) * | 2021-09-28 | 2021-12-31 | 至睿生物(江苏)有限公司 | Edible hydrogel, preparation method and application thereof, and intragastric filler comprising edible hydrogel |
CN114381014B (en) * | 2021-12-16 | 2023-02-17 | 佑道(天津)健康咨询有限公司 | Biodegradable hydrogel and application thereof |
KR102441137B1 (en) * | 2022-02-07 | 2022-09-06 | 김환철 | A biocompatible polymer hydrogel comprising an ether group capable of controlling the degradation rate |
CN114702734A (en) * | 2022-04-08 | 2022-07-05 | 重庆师范大学 | Cellulose ether gel and preparation method and application thereof |
US20240084195A1 (en) * | 2022-09-12 | 2024-03-14 | Kannar Earth Science, Ltd. | Compositions and methods for improving soil condition |
CN116162289B (en) * | 2022-12-06 | 2024-03-15 | 四川兴泰普乐医疗科技有限公司 | Multiple crosslinked sodium carboxymethyl cellulose gel, preparation method and application |
CN118436071A (en) * | 2024-07-08 | 2024-08-06 | 浙江衡美健康科技股份有限公司 | Hydrogel for controlling diet and inducing satiety as well as preparation method and application thereof |
Family Cites Families (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3526048A (en) | 1967-06-07 | 1970-09-01 | Us Agriculture | Cellulose fibers cross-linked and esterified with polycarboxylic acids |
US3589364A (en) | 1968-03-14 | 1971-06-29 | Buckeye Cellulose Corp | Bibulous cellulosic fibers |
JPS55500785A (en) | 1978-10-12 | 1980-10-16 | ||
JPS5885813A (en) * | 1981-11-17 | 1983-05-23 | Toyo Jozo Co Ltd | Drug preparation having high absorbability |
DD212969A1 (en) * | 1982-12-30 | 1984-08-29 | Adw Inst Polymerenchemie | PROCESS FOR MODIFYING CARBOXYMETHYL CELLULOSE |
ZA841044B (en) * | 1983-02-17 | 1984-09-26 | Merrell Dow Pharma | Dry mix cellulose ether compositions as bulk laxatives |
DE3478445D1 (en) * | 1983-10-06 | 1989-07-06 | Kohjin Co | Process for preparing carboxymethyl ethyl cellulose suitable for enteric coating |
JPS62141001A (en) * | 1985-12-13 | 1987-06-24 | Dai Ichi Kogyo Seiyaku Co Ltd | Production of water-soluble alkali metal salt of carboxyalkylcellulose |
US5047513A (en) * | 1986-07-10 | 1991-09-10 | Hoffmann-La Roche Inc. | Metal chelate resins |
JPH0672106B2 (en) * | 1987-04-22 | 1994-09-14 | 花王株式会社 | Laxative composition |
IT1219587B (en) * | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | SELF-CROSS-LINKED CARBOXYLY POLYSACCHARIDES |
DE3903672C1 (en) * | 1989-02-08 | 1990-02-01 | Lohmann Gmbh & Co Kg | |
US5137537A (en) | 1989-11-07 | 1992-08-11 | The Procter & Gamble Cellulose Company | Absorbent structure containing individualized, polycarboxylic acid crosslinked wood pulp cellulose fibers |
US5190563A (en) * | 1989-11-07 | 1993-03-02 | The Proctor & Gamble Co. | Process for preparing individualized, polycarboxylic acid crosslinked fibers |
EP0544671A4 (en) | 1990-04-18 | 1993-09-15 | The University Of Utah | Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting ph-dependent swelling |
US5111886A (en) * | 1991-05-07 | 1992-05-12 | Union Oil Company Of California | Crosslinked hydroxyethylcellulose and its uses |
US5207934A (en) * | 1991-05-07 | 1993-05-04 | Union Oil Company Of California | Crosslinked hydroxyethylcellulose and its uses |
US5247072A (en) | 1991-10-25 | 1993-09-21 | Kimberly-Clark Corporation | Carboxyalkyl polysaccharides having improved absorbent properties and process for the preparation thereof |
US5550189A (en) * | 1992-04-17 | 1996-08-27 | Kimberly-Clark Corporation | Modified polysaccharides having improved absorbent properties and process for the preparation thereof |
JPH08509511A (en) * | 1993-05-03 | 1996-10-08 | ヒェミッシェ ファブリーク シュトックハウセン ゲー.エム.ベー.ハー | Polymer composition, process for producing polymer composition, in particular absorbent composition, and use thereof |
PL173739B1 (en) * | 1993-05-03 | 1998-04-30 | Stockhausen Chem Fab Gmbh | Polymeric composition, absorptive material composition, methods of obtaining the both and their application |
JP3274550B2 (en) * | 1993-08-03 | 2002-04-15 | 株式会社日本触媒 | Manufacturing method of water absorbing material |
ATE173773T1 (en) | 1994-03-18 | 1998-12-15 | Procter & Gamble | THE PRODUCTION OF INDIVIDUAL CELLULOSE FIBERS CROSS-LINKED WITH POLYCARBOXYLIC ACID |
WO1996002276A2 (en) | 1994-07-18 | 1996-02-01 | Gel Sciences, Inc. | Novel polymer gel networks and methods of use |
AU710648B2 (en) | 1994-12-09 | 1999-09-23 | Procter & Gamble Company, The | Absorbent composites and absorbent articles containing the same |
US6060534A (en) * | 1996-07-11 | 2000-05-09 | Scimed Life Systems, Inc. | Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties |
US20010006677A1 (en) | 1996-10-29 | 2001-07-05 | Mcginity James W. | Effervescence polymeric film drug delivery system |
DE19654745C5 (en) * | 1996-12-30 | 2004-01-22 | Lechner, M.D., Prof. Dr. | Biodegradable absorbent, its manufacture and use |
US6271278B1 (en) | 1997-05-13 | 2001-08-07 | Purdue Research Foundation | Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties |
WO1998058686A1 (en) | 1997-06-24 | 1998-12-30 | SCA Mölnlycke AB | Absorbent polymer material based on renewable starting materials |
US5948829A (en) * | 1997-11-25 | 1999-09-07 | Kimberly-Clark Worldwide, Inc. | Process for preparing an absorbent foam |
CO5070628A1 (en) * | 1997-11-25 | 2001-08-28 | Kimberly Clark Co | ABSORBENT FOAM THAT INCLUDES A POLYMER, THE ABSORBENT PRODUCT THAT UNDERSTANDS IT AND THE PROCESS FOR PREPARATION |
JP2000060487A (en) * | 1998-08-27 | 2000-02-29 | Kao Corp | Constipation improver |
AU1908500A (en) | 1998-11-30 | 2000-06-19 | Hercules Incorporated | Controlled release carbohydrate embedded in a crosslinked polysaccharide |
CA2356849C (en) * | 1998-12-16 | 2008-06-03 | Sca Hygiene Products Zeist B.V. | Acidic superabsorbent polysaccharides |
US6471824B1 (en) | 1998-12-29 | 2002-10-29 | Weyerhaeuser Company | Carboxylated cellulosic fibers |
CA2363048A1 (en) * | 1999-02-23 | 2000-08-31 | Phairson Medical, Inc. | Treatment of trauma |
US6207699B1 (en) * | 1999-06-18 | 2001-03-27 | Richard Brian Rothman | Pharmaceutical combinations for treating obesity and food craving |
US6867346B1 (en) * | 1999-09-21 | 2005-03-15 | Weyerhaeuser Company | Absorbent composite having fibrous bands |
GB9924636D0 (en) * | 1999-10-18 | 1999-12-22 | Norgine Bv | Laxative preparation |
EP1134232A1 (en) | 2000-03-16 | 2001-09-19 | SCA Hygiene Products AB | Polysaccharide-based superabsorbent film |
RU2002133855A (en) * | 2000-05-15 | 2004-06-27 | Кимберли-Кларк Ворлдвайд, Инк. (Us) | POLYSACCHARIDE ABSORBENT AND METHOD FOR PRODUCING IT |
US6475530B1 (en) * | 2000-05-31 | 2002-11-05 | Eric H. Kuhrts | Methods and compositions for producing weight loss |
US6476006B2 (en) * | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
CA2351253A1 (en) * | 2000-11-10 | 2002-05-10 | Groupe Lysac Inc./Lysac Group Inc. | Crosslinked polysaccharide, obtained by crosslinking with substituted polyethylene glycol, as superabsorbent |
US8263112B2 (en) * | 2000-11-20 | 2012-09-11 | Sorbent Therapeutics, Inc. | In vivo use of water absorbent polymers |
EP1390085B1 (en) * | 2001-05-01 | 2009-08-05 | A.V. Topchiev Institute of Petrochemical Synthesis | Hydrogel compositions |
DE10125599A1 (en) * | 2001-05-25 | 2002-11-28 | Stockhausen Chem Fab Gmbh | Super-absorbent polymer powder for use in e.g. diapers, packaging and soil improvers, obtained by pre-swelling polycarboxy-polysaccharide in water and then drying and surface-crosslinking resulting hydrogel |
WO2003002623A1 (en) * | 2001-06-28 | 2003-01-09 | Basf Aktiengesellschaft | Acidic hydrogels which are capable of swelling |
WO2003089506A1 (en) * | 2002-04-22 | 2003-10-30 | Purdue Research Foundation | Hydrogels having enhanced elasticity and mechanical strength properties |
JP4132993B2 (en) * | 2002-06-03 | 2008-08-13 | 住友精化株式会社 | Water absorbent resin and method for producing the same |
US7648619B2 (en) | 2002-06-04 | 2010-01-19 | Industrial Technology Research | Hydrogel-driven micropump |
WO2004056343A1 (en) | 2002-12-19 | 2004-07-08 | Polymorfix, Inc. | Ingestible formulations for transient, noninvasive reduction of gastric volume |
CA2521420A1 (en) | 2003-04-08 | 2004-10-28 | Progenics Pharmaceuticals, Inc. | Combination therapy for constipation comprising a laxative and a peripheral opioid antagonist |
CA2638788A1 (en) * | 2003-04-25 | 2004-11-11 | Kos Life Sciences, Inc. | Formation of strong superporous hydrogels |
US20050005870A1 (en) * | 2003-07-11 | 2005-01-13 | The Clorox Company | Composite absorbent particles |
WO2005036971A1 (en) | 2003-10-16 | 2005-04-28 | Techcom Group, Llc | Reduced digestible carbohydrate food having reduced blood glucose response |
US8128958B2 (en) | 2003-11-10 | 2012-03-06 | Astellas Pharma Inc. | Sustained release pharmaceutical composition |
US20050143571A1 (en) * | 2003-12-30 | 2005-06-30 | Weyerhaeuser Company | Method for forming individualized intrafiber crosslinked cellulosic fibers with improved brightness and color |
TW200533391A (en) * | 2004-03-25 | 2005-10-16 | Sun Pharmaceutical Ind Ltd | Gastric retention drug delivery system |
EP1769004B1 (en) * | 2004-06-21 | 2017-08-09 | Evonik Degussa GmbH | Water-absorbing polysaccharide and method for producing the same |
EP1833309A1 (en) | 2004-12-08 | 2007-09-19 | Unilever Plc | Satiety enhancing food product and a method for manufacturing such |
US20070059350A1 (en) * | 2004-12-13 | 2007-03-15 | Kennedy John P | Agents for controlling biological fluids and methods of use thereof |
ITTO20040918A1 (en) * | 2004-12-29 | 2005-03-29 | Luigi Ambrosio | POLYMERIC HYDROGEL BIODEGRADABLE ABSORBERS AND PROCEDURE FOR THEIR PREPARATION |
US20060142561A1 (en) * | 2004-12-29 | 2006-06-29 | Mengkui Luo | Carboxyalkyl cellulose |
US7300965B2 (en) * | 2004-12-29 | 2007-11-27 | Weyerhaeuser Company | Mixed polymer network |
US20060142478A1 (en) * | 2004-12-29 | 2006-06-29 | Mengkui Luo | Carboxyalkyl cellulose polymer network |
US7541396B2 (en) * | 2004-12-29 | 2009-06-02 | Weyerhaeuser Nr Company | Method for making carboxyalkyl cellulose |
US20060142480A1 (en) * | 2004-12-29 | 2006-06-29 | Mengkui Luo | Method of making carboxyalkyl cellulose polymer network |
FR2882366B1 (en) * | 2005-02-18 | 2008-04-18 | Coletica Sa | RETICULATED CARBOHYDRATE POLYMER, IN PARTICULAR BASED ON POLYSACCHARIDES AND / OR POLYOLS |
EP2012752A4 (en) | 2006-03-28 | 2013-03-06 | Gelesis Inc | Use of polymeric materials with other substances for improved performance |
EP2007824B1 (en) | 2006-03-30 | 2013-07-17 | Exotech Bio Solutions Ltd. | Styrene-maleic anhydride copolymers for bioapplications and their preparation |
BRPI0709891A2 (en) | 2006-03-30 | 2011-07-26 | Gelesis Inc | polymeric materials such as stomach filling and its preparation |
US20080075785A1 (en) * | 2006-09-22 | 2008-03-27 | San-Laung Chow | Controlled release hydrogel formulation |
US20080147026A1 (en) * | 2006-12-15 | 2008-06-19 | Jian Qin | Absorbent fiber with a low absorbent capacity and slow absorption rate |
JP2008285611A (en) * | 2007-05-18 | 2008-11-27 | Daicel Chem Ind Ltd | Process for producing crosslinked gel and its crosslinked gel |
MX2010001629A (en) * | 2007-08-10 | 2010-08-09 | Alessandro Sannino | Polymer hydrogels and methods of preparation thereof. |
US8039683B2 (en) * | 2007-10-15 | 2011-10-18 | Kimberly-Clark Worldwide, Inc. | Absorbent composites having improved fluid wicking and web integrity |
AU2009316622B2 (en) | 2008-11-18 | 2014-09-04 | Gelesis Llc | Methods and compositions for weight management and for improving glycemic control |
CN103917092B (en) * | 2011-06-07 | 2018-04-24 | 珍尔希斯股份有限公司 | The method for producing hydrogel |
CN115381850A (en) * | 2014-06-20 | 2022-11-25 | 吉莱斯公司 | Method for treating overweight or obesity |
EP3250612B1 (en) * | 2015-01-29 | 2020-12-02 | Gelesis LLC | Method for producing hydrogels coupling high elastic modulus and absorbance |
RU2745992C2 (en) | 2016-04-25 | 2021-04-05 | Джелесис ЭлЭлСи | Obstipation treatment method |
-
2007
- 2007-08-10 MX MX2010001629A patent/MX2010001629A/en active IP Right Grant
- 2007-08-10 WO PCT/IT2007/000584 patent/WO2009022358A1/en active Application Filing
-
2008
- 2008-08-08 DK DK12176918T patent/DK2532685T3/en active
- 2008-08-08 PT PT121586333T patent/PT2463308E/en unknown
- 2008-08-08 ES ES12176918.6T patent/ES2526905T3/en active Active
- 2008-08-08 HU HUE12158633A patent/HUE024121T2/en unknown
- 2008-08-08 JP JP2010520475A patent/JP5485151B2/en active Active
- 2008-08-08 EP EP20120176382 patent/EP2535359A1/en not_active Withdrawn
- 2008-08-08 CN CN200880104399.0A patent/CN101796075B/en active Active
- 2008-08-08 ES ES08785471.7T patent/ES2554163T3/en active Active
- 2008-08-08 EP EP20120176918 patent/EP2532685B1/en active Active
- 2008-08-08 PL PL12158633T patent/PL2463308T3/en unknown
- 2008-08-08 SI SI200831356T patent/SI2463308T1/en unknown
- 2008-08-08 RU RU2010105385/04A patent/RU2493170C2/en active
- 2008-08-08 ES ES12158633.3T patent/ES2526788T3/en active Active
- 2008-08-08 DK DK12158633.3T patent/DK2463308T3/en active
- 2008-08-08 WO PCT/EP2008/006582 patent/WO2009021701A2/en active Application Filing
- 2008-08-08 EP EP08785471.7A patent/EP2178922B1/en active Active
- 2008-08-08 CN CN201410126564.XA patent/CN104327191A/en active Pending
- 2008-08-08 AU AU2008286354A patent/AU2008286354B2/en active Active
- 2008-08-08 EP EP20120176381 patent/EP2514444A1/en not_active Withdrawn
- 2008-08-08 SI SI200831372T patent/SI2532685T1/en unknown
- 2008-08-08 HU HUE12176918A patent/HUE024123T2/en unknown
- 2008-08-08 CA CA2695974A patent/CA2695974C/en active Active
- 2008-08-08 PT PT121769186T patent/PT2532685E/en unknown
- 2008-08-08 EP EP20120158633 patent/EP2463308B1/en active Active
- 2008-08-08 PL PL12176918T patent/PL2532685T3/en unknown
-
2010
- 2010-02-10 US US12/703,286 patent/US8658147B2/en active Active
-
2012
- 2012-06-19 HK HK12106017.2A patent/HK1172633A1/en unknown
-
2013
- 2013-06-13 RU RU2013126920A patent/RU2641749C2/en active
- 2013-11-18 JP JP2013238364A patent/JP5760069B2/en active Active
-
2014
- 2014-01-08 US US14/150,430 patent/US20140296507A1/en not_active Abandoned
-
2015
- 2015-02-02 HR HRP20150121TT patent/HRP20150121T1/en unknown
- 2015-02-02 CY CY20151100108T patent/CY1115978T1/en unknown
- 2015-02-02 CY CY20151100109T patent/CY1115980T1/en unknown
- 2015-06-08 JP JP2015115944A patent/JP2015212388A/en active Pending
-
2016
- 2016-06-17 US US15/185,443 patent/US10086014B2/en active Active
-
2017
- 2017-09-14 JP JP2017176735A patent/JP7027083B2/en active Active
-
2019
- 2019-08-21 US US16/546,722 patent/US20200046755A1/en not_active Abandoned
-
2020
- 2020-01-10 JP JP2020002831A patent/JP2020097741A/en not_active Withdrawn
-
2021
- 2021-05-28 US US17/333,424 patent/US20210353665A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210353665A1 (en) | Polymer Hydrogels and Methods of Preparation Thereof | |
US11130823B2 (en) | Method for producing hydrogels | |
AU2016219713B2 (en) | Polymer hydrogels and methods of preparation thereof | |
AU2013204055B2 (en) | Polymer hydrogels and methods of preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA MK RS |
|
17P | Request for examination filed |
Effective date: 20100301 |
|
17Q | First examination report despatched |
Effective date: 20100712 |
|
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Ref document number: 602008040541 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: C08B0015100000 Ipc: C08B0015000000 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C08J 3/24 20060101ALI20140801BHEP Ipc: C08B 11/20 20060101ALI20140801BHEP Ipc: C08B 15/00 20060101AFI20140801BHEP |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: SANNINO, ALESSANDRO Inventor name: DEMITRI, CHRISTIAN Inventor name: NICOLAIS, LUIGI Inventor name: AMBROSIO, LUIGI |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20141031 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: GELESIS LLC |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20150325 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 753718 Country of ref document: AT Kind code of ref document: T Effective date: 20151015 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602008040541 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2554163 Country of ref document: ES Kind code of ref document: T3 Effective date: 20151216 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20151007 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 753718 Country of ref document: AT Kind code of ref document: T Effective date: 20151007 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160107 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160207 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160108 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160208 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602008040541 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 |
|
26N | No opposition filed |
Effective date: 20160708 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160831 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160831 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160808 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160808 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20080808 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160831 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151007 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230711 Year of fee payment: 16 Ref country code: ES Payment date: 20230905 Year of fee payment: 16 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240807 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240805 Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240808 Year of fee payment: 17 |